1
|
Wood C, Saltera Z, Garcia I, Nguyen M, Rios A, Oropeza J, Ugwa D, Mukherjee U, Sehar U, Reddy PH. Age-associated changes in the heart: implications for COVID-19 therapies. Aging (Albany NY) 2025; 17:206251. [PMID: 40372276 DOI: 10.18632/aging.206251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2025] [Accepted: 04/22/2025] [Indexed: 05/16/2025]
Abstract
Cardiac aging involves progressive structural, functional, cellular, and molecular changes that impair heart function. This review explores key mechanisms, including oxidative stress, mitochondrial dysfunction, impaired autophagy, and chronic low-grade inflammation. Excess reactive oxygen species (ROS) damage heart muscle cells, contributing to fibrosis and cellular aging. Mitochondrial dysfunction reduces energy production and increases oxidative stress, accelerating cardiac decline. Impaired autophagy limits the removal of damaged proteins and organelles, while inflammation activates signaling molecules that drive tissue remodeling. Gender differences reveal estrogen's protective role in premenopausal women, with men showing greater susceptibility to heart muscle dysfunction and injury. After menopause, women lose this hormonal protection, increasing their risk of cardiovascular conditions. Ethnic disparities, particularly among underserved minority populations, emphasize how social factors such as access to care, environment, and chronic stress contribute to worsening cardiovascular outcomes. The coronavirus disease pandemic has introduced further challenges by increasing the incidence of heart damage through inflammation, blood clots, and long-term heart failure, especially in older adults with existing metabolic conditions like diabetes and high blood pressure. The virus's interaction with receptors on heart and blood vessel cells, along with a weakened immune response in older adults, intensifies cardiac aging. Emerging therapies include delivery of therapeutic extracellular vesicles, immune cell modulation, and treatments targeting mitochondria. In addition, lifestyle strategies such as regular physical activity, nutritional improvements, and stress reduction remain vital to maintaining cardiac health. Understanding how these biological and social factors intersect is critical to developing targeted strategies that promote healthy aging of the heart.
Collapse
Affiliation(s)
- Colby Wood
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
| | - Zach Saltera
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
| | - Isaiah Garcia
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
| | - Michelle Nguyen
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
| | - Andres Rios
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
| | - Jacqui Oropeza
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
| | - Destiny Ugwa
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
| | - Upasana Mukherjee
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
| | - Ujala Sehar
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
| | - P Hemachandra Reddy
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
- Nutritional Sciences Department, College Human Sciences, Texas Tech University, Lubbock, TX 79409, USA
- Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
- Department of Neurology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
- Department of Public Health, Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
- Department of Speech, Language, and Hearing Sciences, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
| |
Collapse
|
2
|
Omission in the Funding and Support Section. JAMA Netw Open 2025; 8:e2516428. [PMID: 40388172 DOI: 10.1001/jamanetworkopen.2025.16428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/20/2025] Open
|
3
|
Kim SY, Wen W, Coulter KM, Tse HW, Du Y, Chen S, Hou Y, Shen Y. Sociocultural Antecedents and Mechanisms of COVID-19 Vaccine Uptake among Mexican-Origin Youth. Behav Med 2025; 51:94-105. [PMID: 38874131 PMCID: PMC11645438 DOI: 10.1080/08964289.2024.2355117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Revised: 02/26/2024] [Accepted: 05/09/2024] [Indexed: 06/15/2024]
Abstract
Mexican-origin youth, as a large and growing population among U.S. youth, have been disproportionately affected by COVID-19. Understanding what, when, and how sociocultural factors may influence their COVID-19 vaccine uptake could inform current and future pandemic-response interventions promoting vaccination behaviors among Mexican-origin youth. The current study takes a developmental approach to reveal the long-term and short-term sociocultural antecedents of 198 Mexican-origin adolescents' COVID-19 vaccination uptake behaviors and explores the underlying mechanism of these associations based on the Knowledge-Attitude-Behavior model. The current study adopted Wave 1 (2012-2015) and Wave 4 (2021-2022) self-reported data from a larger study. Analyses were conducted to examine four mediation models for four sociocultural antecedents-daily discrimination, ethnic discrimination, foreigner stress, and family economic stress-separately. Consistent indirect effects of higher levels of concurrent sociocultural risk factors on a lower probability of COVID-19 vaccine uptake were observed to occur through less knowledge about the COVID-19 vaccines and less positive attitudes toward the COVID-19 vaccines at Wave 4. Significant direct effects, but in opposite directions, were found for the associations between Wave 1 ethnic discrimination/Wave 4 daily discrimination and the probability of COVID-19 vaccine uptake. The findings highlight the importance of considering prior and concurrent sociocultural antecedents and the Knowledge-Attitude-Behavior pathway leading to COVID-19 vaccination uptake among Mexican-origin youth and suggest that the impact of discrimination on COVID-19 vaccination uptake may depend on the type (e.g., daily or ethnic) and the context (e.g., during the COVID-19 pandemic or not) of discrimination experienced.
Collapse
Affiliation(s)
- Su Yeong Kim
- Department of Human Development and Family Sciences, The University of Texas at Austin, Austin, TX, USA
| | - Wen Wen
- Department of Human Development and Family Sciences, The University of Texas at Austin, Austin, TX, USA
| | - Kiera M Coulter
- Population Research Center, The University of Texas at Austin, Austin, TX, USA
| | - Hin Wing Tse
- Department of Human Development and Family Sciences, The University of Texas at Austin, Austin, TX, USA
| | - Yayu Du
- Department of Human Development and Family Sciences, The University of Texas at Austin, Austin, TX, USA
| | - Shanting Chen
- Department of Psychology, University of Florida, Gainesville, FL, USA
| | - Yang Hou
- Department of Behavioral Sciences and Social Medicine, Florida State University, Tallahassee, FL, USA
| | - Yishan Shen
- School of Family and Consumer Sciences, Texas State University, San Marcos, TX, USA
| |
Collapse
|
4
|
Smith BD, Matungwa DJ, Huang T, Newton M, Cannon P, Williams M, Foster MW. Leveraging the Arts to Address and Elevate Vaccine Confidence: A Culturally Responsive and Equitable Evaluation of an Arts Intervention for Black Residents in Rural Georgia. QUALITATIVE HEALTH RESEARCH 2025; 35:539-553. [PMID: 40171588 DOI: 10.1177/10497323251316824] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/03/2025]
Abstract
Despite pronounced disparities in COVID-19 cases and mortality among communities of color in the United States, and vaccines being a potentially lifesaving prevention measure, vaccination rates are still lower among racial minorities, especially Black people, compared to White people. Reasons such as distrust in the U.S. government and healthcare system underlie vaccine deliberation, which contributes to low vaccine uptake among Black people. The creative and community-based program, "Equitable Vaccines," uses the arts to address vaccine deliberation and boost vaccine confidence among Black people in rural Georgia. Program facilitators implemented vaccine events, bringing together community members to view an artistic asset (e.g., creative short film) and engage participants in candid conversations surrounding COVID-19 and vaccine deliberation. Subsequently, participants were invited to receive a COVID vaccine and complete a brief online post-event survey. Program facilitators also reported their observations and interactions with participants via an Asana post-event report. An analysis of these fieldnotes highlights the community's evolving experiences with COVID-19, the vaccine, and reasons for vaccine deliberation between late 2021 and 2024. Findings revealed that mistrust in U.S. institutions and systems and misinformation was a prominent theme across the entire program duration, but there was also a shift toward motivation for getting vaccinated toward the latter part of the program. We recommend using creative and culturally responsive techniques in designing, implementing, and evaluating public health interventions to address vaccine deliberation and other public health concerns in Black communities across the United States.
Collapse
Affiliation(s)
| | - Dunstan J Matungwa
- Performance Hypothesis, Atlanta, GA, USA
- National Institute for Medical Research, Mwanza, Tanzania
| | - Tracy Huang
- Performance Hypothesis, Atlanta, GA, USA
- Emory University Rollins School of Public Health, Atlanta, GA, USA
| | | | | | | | | |
Collapse
|
5
|
Soto-Vásquez AD, Gonzalez AA, Garza Garza E, Shi W, Garcia N. The Cultural Influence of Familismo in Prompting Vaccination Against COVID-19 Among U.S. Latina/o/x Border Residents. HEALTH COMMUNICATION 2025; 40:563-573. [PMID: 38744433 DOI: 10.1080/10410236.2024.2353418] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/16/2024]
Abstract
This study centers on familismo as a relevant cultural construct that adds a U.S. Latina/o/x perspective to the Health Belief Model. Employing a qualitative lens, we use in-depth semi-structured focus groups and interviews with participants living, working, and attending school in a mid-size city on the U.S./Mexico border on the decision to take the COVID-19 vaccine. We find that, for many members of these communities, getting vaccinated is seen as a way to protect not only oneself but also one's family, especially those with chronic health conditions, reflecting an obligation to prioritize the collective over the individual. We highlight various approaches that families take to discuss COVID-19 vaccines, ranging from women coordinating vaccination to a non-confrontational approach to the unvaccinated. The borderlands as a place also showcase the diversity of the U.S. Latina/o/x experience during the pandemic, since the perceived disparities of vaccine access in Mexico also seemed to cue the decision to get vaccinated. We propose this helps explain the exceptionally high vaccination rate in the city under study and seen in several other border communities. By illuminating how familial ties impact health communication surrounding this important issue, this study adds an expanded Latina/o/x cultural context for aspects of the Health Belief Model such as perceived severity and susceptibility.
Collapse
Affiliation(s)
| | - Ariadne A Gonzalez
- Department of Psychology and Communication, Texas A&M International University
| | - Edith Garza Garza
- Department of Psychology and Communication, Texas A&M International University
| | - Wanzhu Shi
- Department of Political Science and Public Administration, University of North Florida
| | - Nilda Garcia
- Department of Social Sciences, Texas A&M International University
| |
Collapse
|
6
|
Htet H, Wichaidit W, Chuaychai A, Sottiyotin T, Htet KKK, Sriplung H, Chongsuvivatwong V. Perspectives of stakeholders on barriers to COVID-19 protective behaviors adherence and vaccination among Myanmar migrant workers in southern Thailand: A qualitative study. PLoS One 2025; 20:e0317714. [PMID: 40067860 PMCID: PMC11896050 DOI: 10.1371/journal.pone.0317714] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2024] [Accepted: 01/02/2025] [Indexed: 03/15/2025] Open
Abstract
Studies have been conducted on migrant health during the COVID-19 pandemic. However, in-depth information is scarce regarding the barriers to preventing COVID-19 in this vulnerable population. The objective of the study is to explore the barriers to COVID-19 protective behaviors adherence and vaccination among Myanmar migrant workers in Thailand. We conducted an interview-based qualitative study among 7 migrants from Myanmar, 6 Thai employers, and 9 Thai healthcare providers in the cities of Hat Yai and Pattani in Southern Thailand. We recruited participants by purposive sampling. We conducted in-depth interviews in-person or via telephone in Thai or Burmese language, transcribed the interview, and conducted thematic analysis. Regarding adherence to COVID-19 protective behaviors, two themes emerged: lifestyle and habit-related barriers, and non-vaccine supply chain management barriers. Regarding COVID-19 vaccination, three common themes emerged: fear, barriers related to health education and health promotion, and vaccine supply chain management. Supply chain management was a common theme in both domains. However, each domain also had additional themes. Our study contributed empirical findings that could be of interest to stakeholders in migrant health. However, limitations regarding the generalizability of the findings and social desirability should be considered in the interpretation of the findings.
Collapse
Affiliation(s)
- Hein Htet
- Department of Epidemiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla Province, Thailand
- Department of Preventive and Social Medicine, University of Medicine (Taunggyi), Ministry of Health, Myanmar
| | - Wit Wichaidit
- Department of Epidemiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla Province, Thailand
| | - Aungkana Chuaychai
- Department of Pharmaceutical Care, School of Pharmacy, Walailak University, Nakhon Si Thammarat Province, Thailand
| | - Tiida Sottiyotin
- Department of Pharmaceutical Care, School of Pharmacy, Walailak University, Nakhon Si Thammarat Province, Thailand
| | | | - Hutcha Sriplung
- Department of Epidemiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla Province, Thailand
| | - Virasakdi Chongsuvivatwong
- Department of Epidemiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla Province, Thailand
| |
Collapse
|
7
|
Martell R, Reade M, Boesch L, Kaur DP, Kumar S, McArthur M, Maar MA. The role of narratives in promoting vaccine confidence among Indigenous peoples in Canada, the United States, Australia, and New Zealand: a scoping review. Int J Equity Health 2025; 24:63. [PMID: 40045382 PMCID: PMC11884110 DOI: 10.1186/s12939-025-02424-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2024] [Accepted: 02/22/2025] [Indexed: 03/09/2025] Open
Abstract
BACKGROUND Many Indigenous youth and young adults in Canada, the United States, Australia, and New Zealand have reported low vaccine confidence, which has been linked to lower vaccination rates for COVID-19, MMR, HPV, DTaP-IPV-Hib, and pneumococcal conjugate vaccines. Narrative-based health promotion approaches, including those focused on strengthening vaccine confidence, have been used in public health interventions. Scoping reviews have become increasingly valued for their rigorous and reproducible exploration of evidence in public health research. The aim of this scoping review was to understand the extent and types of evidence related to the facilitators, challenges, and benefits of narrative-based health promotion approaches in vaccine confidence interventions within Indigenous populations. METHODS This review adhered to the Joanna Briggs Institute (JBI) guidelines for scoping reviews using Covidence online software to streamline the review process. Database searches were conducted in MEDLINE, Embase, Web of Science, PsycINFO, and PubMed, as well as Google search to identify both academic and gray literature articles on the role of narratives in promoting vaccine confidence published between January 2000 and April 2024. Charted data were ranked in a numerical summary and analyzed using qualitative content analysis. The review process embraced a two-eyed seeing approach. RESULTS The searches identified 306 records. After the screening process, 45 sources (35 peer-reviewed articles, eight gray literature, and two preprint articles) were included in the final review. The key facilitators of narrative-based approaches to promote vaccine confidence were community engagement, tailored and culturally safe interventions, and trusted messengers and sources of information. The challenges discussed in the literature were linked to mistrust of government and healthcare services and to misinformation narratives. The most frequently reported benefits were the development of community-based resources, culturally safe and relevant interventions, building trust and respectful relationships, and improved vaccination rates. CONCLUSION This review confirmed the important contribution of narrative-based health promotion approaches in strengthening vaccine confidence among Indigenous populations. This finding underscores the importance of respecting Indigenous sovereignty and engaging community perspectives to repair trust and improve vaccination rates.
Collapse
Affiliation(s)
- Robert Martell
- School of Kinesiology and Health Sciences, Laurentian University, 935 Ramsey Lake Rd., Sudbury, ON, P3E 2C6, Canada
| | - Maurianne Reade
- Clinical Sciences Division, Northern Ontario School of Medicine (NOSM) University, 935 Ramsey Lake Rd., Sudbury, ON, P3E 2C6, Canada
| | - Lisa Boesch
- Human Sciences Division, Northern Ontario School of Medicine (NOSM) University, 935 Ramsey Lake Rd., Sudbury, ON, P3E 2C6, Canada
| | - Davinder P Kaur
- Postgraduate Medical Education, Northern Ontario School of Medicine (NOSM) University, 955 Oliver Rd., Thunder Bay, ON, P7B 5E1, Canada
| | - Sandeep Kumar
- Postgraduate Medical Education, Northern Ontario School of Medicine (NOSM) University, 955 Oliver Rd., Thunder Bay, ON, P7B 5E1, Canada
| | - Michael McArthur
- Health Sciences Library, Northern Ontario School of Medicine (NOSM) University, 935 Ramsey Lake Rd., Sudbury, ON, P3E 2C6, Canada
| | - Marion A Maar
- Human Sciences Division, Northern Ontario School of Medicine (NOSM) University, 935 Ramsey Lake Rd., Sudbury, ON, P3E 2C6, Canada.
| |
Collapse
|
8
|
Streuli S, Servin AE, Salgin L, Muñoz FA, Smith DM, Stockman JK, O'Bryan SE, Ramirez D, James-Price C, Skaathun B. Chronic conditions, COVID-19 vaccination, and institutional trust among Hispanic/Latinx communities in San Diego, California. Prev Med 2025; 192:108240. [PMID: 39909210 DOI: 10.1016/j.ypmed.2025.108240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/10/2024] [Revised: 01/30/2025] [Accepted: 01/31/2025] [Indexed: 02/07/2025]
Abstract
BACKGROUND Hispanic/Latinx populations have been disproportionately impacted by the COVID-19 pandemic. These populations are also more likely to have chronic conditions, putting them at higher risk of severe COVID-19 outcomes. Vaccination is important to reduce the risk of severe COVID-19 outcomes, but Hispanic/Latinx populations may be less likely to vaccinate due to institutional trust related to experiences of discrimination in healthcare and community disinvestment. Project 2VIDA! is a randomized clinical trial developed to respond to the need for increased trust and vaccine access among these populations in San Diego, California. Analyzing 2VIDA! data, this article seeks to better understand the relationship between chronic health conditions, institutional trust, and vaccination behaviors among a predominantly Hispanic/Latinx sample in San Diego. METHODS We conducted a secondary analysis of baseline survey data collected from July 2021-June 2023 during 2VIDA! We used ordered logistic regression to understand the relationship between chronic conditions, institutional trust, and vaccination among participants. RESULTS Our findings show that participants aged 36 or older, women, those who indicated higher institutional trust in healthcare and health information, and those with one or more chronic conditions had higher odds of receiving more vaccinations. Participants who took the survey in Spanish had lower odds of vaccination (compared to English). CONCLUSIONS Our findings suggest that widespread communication on the importance of vaccination for older Hispanic/Latinx populations with chronic conditions may have supported vaccination uptake. Targeted messaging and community-based approaches to build trust, combat misinformation, and increase vaccination uptake among younger individuals and Spanish-speakers are needed.
Collapse
Affiliation(s)
- Samantha Streuli
- School of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, United States
| | - Argentina E Servin
- School of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, United States
| | - Linda Salgin
- San Ysidro Health Center, San Diego, CA, United States
| | | | - Davey M Smith
- School of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, United States
| | - Jamila K Stockman
- School of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, United States
| | - Sophie E O'Bryan
- School of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, United States
| | | | | | - Britt Skaathun
- School of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, United States.
| |
Collapse
|
9
|
Zhao J, Jaggad R, Zhang Y, Campbell JE, Ghosh PK, Kennedye JR, Ali T. Multi-level determinants of vaccination of the American Indian and Alaska Native population: a comprehensive overview. Front Public Health 2025; 13:1490286. [PMID: 40041179 PMCID: PMC11877907 DOI: 10.3389/fpubh.2025.1490286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2024] [Accepted: 01/15/2025] [Indexed: 03/06/2025] Open
Abstract
Context American Indians and Alaska Natives (AIANs) are historically disadvantaged, losing 20 million (95%) of their population largely through epidemics since 1,520 and continuing lower overall vaccination coverage than other races. Determinants of this lower coverage are underexamined. Methods Among peer-reviewed relevant articles since 1968, 39 studied AIANs solely; 47 drew general population samples, including AIANs. We employed rigorous economic definitions and framework of Individual Decision-Making Under Uncertainty. The Social-Ecological model identified determinants and mechanisms at five levels. Findings Individual-level determinants include: (1) vaccine-preventable disease (VPD) and vaccine knowledge; (2) vaccine safety, efficacy, moral hazard beliefs; (3) preferences; (4) income and post-subsidy costs. Interpersonal-level determinants include others' knowledge and preferences. Organizational-level characteristics of Indian Health Service, Tribal, Urban Indian (IHS/T/U) facilities include: (1) supply of vaccine products, providers, services; (2) provider cultural competency, vaccine recommendations, standing orders; (3) patient reminder/recall. Community-level characteristics include: (1) socioeconomics and geographics; (2) information infrastructure; (3) cultural values, practices, languages; (4) historical epidemic knowledge; (5) historical harms thus distrust in government, health system, science. Societal-level determinants include: (1) federal recognition and entitlements; (2) tribal self-determination; (3) state Medicaid enrollment; (4) structural racism. Policy recommendations Tribal interventions may (1) increase AIANs' knowledge about VPDs, vaccines, Medicaid enrollment; (2) design risk/cost-benefit calculations using scientific objective probabilities of vaccine safety and efficacy; (3) tailor messages to epidemic histories, narratives, values; (4) outreach by trusted messengers. I/T/U organizational interventions may reduce transportation costs while increasing provider supplies, cultural competency, and vaccine standing orders. Federal policies may increase IHS funding, tribal infrastructure, and AIAN data representativeness while eliminating structural racism and generational trauma. Conclusion This article contributes to literature and practice. It is the first multidisciplinary, comprehensive overview of multi-level determinants and mechanisms of AIAN vaccination. Its findings highlight the gaps and limitations of laws and policies impacting AIAN vaccination. It recommends future research, culturally-appropriate interventions, and policies to close the gap to enhance AIAN vaccination and healing.
Collapse
Affiliation(s)
- Junying Zhao
- Department of Health Administration and Policy, University of Oklahoma Health Sciences, Oklahoma, OK, United States
| | - Rashmi Jaggad
- Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences, Oklahoma, OK, United States
| | - Ying Zhang
- Strong Heart Study/Center for American Indian Health, Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences, Oklahoma, OK, United States
| | - Janis E. Campbell
- Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences, Oklahoma, OK, United States
| | - Pallab K. Ghosh
- Department of Economics, University of Oklahoma, Norman, OK, United States
| | - James R. Kennedye
- Chickasaw Nation Medical Center, Muscogee Creek Nation Medical Center, Department of Emergency Medicine, Kiowa Tribe of Oklahoma, Ada, OK, United States
| | - Tauqeer Ali
- Strong Heart Study/Center for American Indian Health, Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences, Oklahoma, OK, United States
| |
Collapse
|
10
|
Newman PA, Dinh DA, Nyoni T, Allan K, Fantus S, Williams CC, Tepjan S, Reid L, Guta A. Covid-19 Vaccine Hesitancy and Under-Vaccination among Marginalized Populations in the United States and Canada: A Scoping Review. J Racial Ethn Health Disparities 2025; 12:413-434. [PMID: 38117443 PMCID: PMC11746967 DOI: 10.1007/s40615-023-01882-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2023] [Revised: 11/20/2023] [Accepted: 11/27/2023] [Indexed: 12/21/2023]
Abstract
BACKGROUND Amid persistent disparities in Covid-19 vaccination and burgeoning research on vaccine hesitancy (VH), we conducted a scoping review to identify multilevel determinants of Covid-19 VH and under-vaccination among marginalized populations in the U.S. and Canada. METHODS Using the scoping review methodology developed by the Joanna Briggs Institute, we designed a search string and explored 7 databases to identify peer-reviewed articles published from January 1, 2020-October 25, 2022. We combine frequency analysis and narrative synthesis to describe factors influencing Covid-19 VH and under-vaccination among marginalized populations. RESULTS The search captured 11,374 non-duplicated records, scoped to 103 peer-reviewed articles. Among 14 marginalized populations identified, African American/Black, Latinx, LGBTQ+, American Indian/Indigenous, people with disabilities, and justice-involved people were the predominant focus. Thirty-two factors emerged as influencing Covid-19 VH, with structural racism/stigma and institutional mistrust (structural)(n = 71) most prevalent, followed by vaccine safety (vaccine-specific)(n = 62), side effects (vaccine-specific)(n = 50), trust in individual healthcare provider (social/community)(n = 38), and perceived risk of infection (individual)(n = 33). Structural factors predominated across populations, including structural racism/stigma and institutional mistrust, barriers to Covid-19 vaccine access due to limited supply/availability, distance/lack of transportation, no/low paid sick days, low internet/digital technology access, and lack of culturally- and linguistically-appropriate information. DISCUSSION We identified multilevel and complex drivers of Covid-19 under-vaccination among marginalized populations. Distinguishing vaccine-specific, individual, and social/community factors that may fuel decisional ambivalence, more appropriately defined as VH, from structural racism/structural stigma and systemic/institutional barriers to vaccination access may better support evidence-informed interventions to promote equity in access to vaccines and informed decision-making among marginalized populations.
Collapse
Affiliation(s)
- Peter A Newman
- Factor-Inwentash Faculty of Social Work, University of Toronto, Toronto, ON, Canada.
| | - Duy A Dinh
- Factor-Inwentash Faculty of Social Work, University of Toronto, Toronto, ON, Canada
- Faculty of Health Sciences, Queen's University, Kingston, ON, Canada
| | - Thabani Nyoni
- Factor-Inwentash Faculty of Social Work, University of Toronto, Toronto, ON, Canada
| | - Kate Allan
- Factor-Inwentash Faculty of Social Work, University of Toronto, Toronto, ON, Canada
| | - Sophia Fantus
- School of Social Work, University of Texas at Arlington, Arlington, TX, USA
| | - Charmaine C Williams
- Factor-Inwentash Faculty of Social Work, University of Toronto, Toronto, ON, Canada
| | | | - Luke Reid
- Factor-Inwentash Faculty of Social Work, University of Toronto, Toronto, ON, Canada
| | - Adrian Guta
- School of Social Work, University of Windsor, Windsor, ON, Canada
| |
Collapse
|
11
|
Rivas C, Moore AP, Thomson A, Anand K, Lal ZZ, Wu AFW, Aksoy O. Intersecting factors of disadvantage and discrimination and their effect on daily life during the coronavirus pandemic: the CICADA-ME mixed-methods study. HEALTH AND SOCIAL CARE DELIVERY RESEARCH 2025; 13:1-185. [PMID: 39949202 DOI: 10.3310/kytf4381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/09/2025]
Abstract
Background The COVID-19 pandemic exacerbated pre-existing societal inequities. Our study addresses the dearth of studies on how intersecting factors of disadvantage and discrimination affected pandemic daily life for disabled people from minoritised ethnic groups, aiming to improve their experiences and social, health and well-being outcomes. Objectives Through an intersectionality lens, to: explore and compare, by location and time, survey and qualitative data on changing needs for social, health and well-being outcomes relate coping strategies/solutions to these explore formal and informal network issues/affordances gain insights from synthesising our data contextualise and explore transferability of findings co-create outputs with stakeholders. Design Mixed-methods, asset-based, underpinned by embodiment disability models and intersectionality, integrating three strands: (secondary): analysis of existing cohort/panel data, literature review (primary: quantitative): new survey (n = 4326), three times over 18 months (primary: qualitative): semistructured interviews (n = 271), interviewee co-create workshops (n = 104) 5 and 10 months later, mixed stakeholder co-design workshops (n = 30) for rapid-impact solutions to issues, key informant interviews (n = 4). Setting United Kingdom and Republic of Ireland. Participants Strand 2: community-dwelling migrants, White British comparators, with/without disability. Strand 3: focus on Arab, South Asian, African, Central/East European, or White British heritage with/without disability. Results We found strong adherence to pandemic restrictions (where accommodation, economic situations and disability allowed) due to COVID-19 vulnerabilities. High vaccine hesitancy (despite eventual uptake) resulted from side-effect concerns and (mis)trust in the government. Many relied on food banks, local organisations, communities and informal networks. Pandemic-related income loss was common, particularly affecting undocumented migrants. Participants reported a crisis in mental health care, non-holistic social and housing care, and inaccessible, poor-quality and discriminatory remote health/social care. They preferred private care (which they could not easily afford), community or self-help online support. Lower socioeconomic status, mental health and mobility issues reduced well-being. Individual and community assets and coping strategies mitigated some issues, adapted over different pandemic phases, and focused on empowerment, self-reflection, self-care and social connectivity. Technology needs cut across these. Limitations We could not explore area-level social distancing and infection rates. Data collection was largely online, possibly excluding some older, digitally deprived or more disabled participants. Participants engaged differently in online and face-to-face co-create workshops. Our qualitative data over-represent England and South Asian people and use contestable categories. Conclusions Different intersecting factors led to different experiences, with low socioeconomic status particularly significant. Overall, disability and minoritised ethnic identities led to worse pandemic experiences. Our co-design work shows how to build on the assets and strengths; simple changes in professional communication and understanding should improve experience. Minoritised groups can easily be involved in policy and practice decision-making, reducing marginalisation, with better сare and outcomes. Future work More research is needed on: (1) the impact of the post-pandemic economic situation and migration policies on migrant mental health/well-being; (2) supporting empowerment strategies across disadvantaged intersecting identities; and (3) technological deprivation and the cultural and disability-relevant acceptability of remote consultations. We found some differences in the devolved nations, which need elucidation. Study registration This study is registered as ISRCTN40370, PROSPERO CRD42021262590 and CRD42022355254. Funding This award was funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme (NIHR award ref: NIHR132914) and is published in full in Health and Social Care Delivery Research; Vol. 13, No. 2. See the NIHR Funding and Awards website for further award information.
Collapse
Affiliation(s)
- Carol Rivas
- UCL Social Research Institute, University College London (UCL), London, UK
| | - Amanda P Moore
- UCL Social Research Institute, University College London (UCL), London, UK
| | - Alison Thomson
- Wolfson Institute, Queen Mary University of London, London, UK
| | - Kusha Anand
- UCL Social Research Institute, University College London (UCL), London, UK
| | - Zainab Zuzer Lal
- UCL Social Research Institute, University College London (UCL), London, UK
| | - Alison Fang-Wei Wu
- UCL Social Research Institute, University College London (UCL), London, UK
| | - Ozan Aksoy
- UCL Social Research Institute, University College London (UCL), London, UK
| |
Collapse
|
12
|
Hassane Dan Karami NO, Greder K, Bao J, Kim D, Russell D. Vaccine Uptake and Perspectives Among Latina Immigrant Mothers in Rural Communities in a Midwestern State. Am J Health Promot 2025; 39:22-27. [PMID: 39033309 DOI: 10.1177/08901171241266609] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/23/2024]
Abstract
PURPOSE Examine the prevalence of and characteristics related to COVID-19 vaccine uptake. DESIGN Quantitative and qualitative data collected at two-time points via phone interviews. SETTING Rural Midwestern communities. SAMPLE 109 Latina mothers with incomes < 185% FPL, at least one child < age 12 recruited from a Midwestern state based on two previous studies. MEASURES Mothers responded to the following variables through a survey: Vaccine uptake measured by responses to, Have you received a vaccination shot for COVID-19. Tested predictors of vaccine uptake included: income, gender, education, immigration status, confidence in vaccine, belief the pandemic is over). Mothers' perspectives regarding the vaccine explored via responses to Why haven't you received COVID-19 vaccine?. ANALYSIS Binary logistic regression analysis was conducted. Demographic variables and attitudes toward the vaccine served as predictors of mothers' vaccine uptake. Qualitative data were analyzed to shed light on mothers' perspectives on receiving the vaccine. RESULTS Mother's confidence in the vaccine predicted vaccine uptake in 2021 (aOR=1.332, 95% CI: 1.07-1.65) and 2022 (aOR=1.48, 95%CI: 1.11-1.97). In 2021, income also predicted vaccine uptake (aOR=1; 95% CI: 1-1.002). Overarching themes: "vaccination is not necessary","mistrust of the vaccine", and "vaccine as protector". CONCLUSION Vaccinated mothers viewed the vaccine as a protection from being infected or gravely ill. For unvaccinated mothers, messages are needed that communicate the vaccine can protect them from virus transmission from household members who unknowingly are infected, as well as from different virus strains.
Collapse
Affiliation(s)
| | | | - Juan Bao
- University of Iowa, Iowa, IA, USA
| | - Dahee Kim
- University of Central Florida, Storrs, CT, USA
| | | |
Collapse
|
13
|
Peterson JC, Williams E, Goes-Ahead Lopez C, Jansen K, Albers AN, Newcomer SR, Caringi J. Influences on COVID-19 vaccine Decision-Making: A Qualitative Study With Urban Indigenous and Rural Adults. COMMUNITY HEALTH EQUITY RESEARCH & POLICY 2025; 45:195-206. [PMID: 39151928 DOI: 10.1177/2752535x241273816] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 08/19/2024]
Abstract
Despite the safety and effectiveness of the COVID-19 vaccine, public hesitancy about receiving vaccination remains strong among disproportionately affected populations in the United States. To design more locally and culturally appropriate strategies, research is needed to explore the qualitative characteristics of vaccine hesitancy in these populations. Thus, we conducted in-depth interviews with 19 Indigenous and 20 rural participants and utilized a grounded theory approach to identify factors associated with their COVID-19 vaccine decision making. Wariness regarding safety of vaccines, resignation over the quality of available health care, and a historical mistrust of government-led interventions influenced vaccine rejection for indigenous participants. Rural participants remained divided on the perceived threat and consequences of COVID-19 and the efficacy and safety of the vaccines. The influence of friends and family members impacted vaccine hesitancy, as did discussions with healthcare providers when discussions were perceived to be respectful, sensitive, and non-judgmental.
Collapse
Affiliation(s)
- Jeffery Chaichana Peterson
- Center for Population Health Research, University of Montana, Missoula, MT, USA
- School of Public and Community Health Sciences, University of Montana, Missoula, MT, USA
| | - Elizabeth Williams
- Center for Population Health Research, University of Montana, Missoula, MT, USA
- School of Public and Community Health Sciences, University of Montana, Missoula, MT, USA
- All Nations Health Center, Missoula, MT, USA
| | | | - Kelley Jansen
- Center for Alaska Native Health Research, University of Alaska Fairbanks , Fairbanks, AK, USA
| | - Alexandria N Albers
- Center for Population Health Research, University of Montana, Missoula, MT, USA
- School of Public and Community Health Sciences, University of Montana, Missoula, MT, USA
| | - Sophia R Newcomer
- Center for Population Health Research, University of Montana, Missoula, MT, USA
- School of Public and Community Health Sciences, University of Montana, Missoula, MT, USA
| | - James Caringi
- Center for Population Health Research, University of Montana, Missoula, MT, USA
- School of Public and Community Health Sciences, University of Montana, Missoula, MT, USA
| |
Collapse
|
14
|
Guidry JP, Naavaal S, Laestadius LI, Miller CA, Zurlo G, Burton CW, Carlyle KE, Russo J, Perrin PB. Health, beliefs, and faith: HPV vaccine uptake intent among Catholic, Evangelical, and mainline protestant parents. Hum Vaccin Immunother 2024; 20:2425142. [PMID: 39653069 PMCID: PMC11633157 DOI: 10.1080/21645515.2024.2425142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2024] [Revised: 10/18/2024] [Accepted: 10/30/2024] [Indexed: 12/13/2024] Open
Abstract
The HPV vaccine has the potential to prevent nearly 92% of HPV-related cancer cases, yet its uptake remains suboptimal. While well-documented barriers to HPV vaccine uptake include inadequate knowledge and lack of provider recommendation, religious preferences have emerged as another crucial factor influencing vaccination decisions. This study examined the interrelatedness of religion, beliefs, and HPV vaccination uptake among children among Catholic, Evangelical, and Mainline Protestant parents. A nationally representative survey was conducted among 1,068 U.S. parents from one of three major Christian denominations: Catholic, Evangelical, or Mainline Protestant. We examined the extent to which demographic factors, constructs from the Health Belief Model (perceived severity, susceptibility, benefits, barriers, self-efficacy, and cues to action), and faith-based support variables contributed to HPV vaccination decisions among parents from the specified religious denominations. Among the surveyed parents, 72.3% indicated that their child had received the HPV vaccine, revealing a substantial but incomplete uptake rate. Notably, no statistically significant differences were observed in vaccination rates across the three denominational groups. Perceived HPV vaccine benefits (p < .001), perceived barriers (p < .001) and perceived self-efficacy (p = .013) were strongly associated. Parents reporting that their child's healthcare provider asked them about the vaccine (p < .001) and those more receptive to faith-based support for HPV vaccination (p = .049) were more likely to report child HPV vaccine uptake. To enhance HPV vaccine uptake among the examined religious denominations, strengthening provider-parent communication regarding the HPV vaccine and fostering partnerships between healthcare providers and supportive religious congregations can serve as powerful levers for promoting vaccination acceptance and compliance.
Collapse
Affiliation(s)
- Jeanine P.D. Guidry
- Department of Communication and Cognition, Tilburg University, Tilburg, The Netherlands
| | - Shillpa Naavaal
- Department of Dental Public Health and Policy, Virginia Commonwealth University School of Dentistry, Richmond, VA, USA
| | - Linnea I. Laestadius
- Joseph J. Zilber College of Public Health, University of Wisconsin-Milwaukee, Milwaukee, WI, USA
| | - Carrie A. Miller
- Department of Family Medicine and Population Health, Virginia Commonwealth University School of Medicine, Richmond, VA, USA
| | - Gina Zurlo
- Harvard Divinity School, Cambridge, MA, USA
| | - Candace W. Burton
- School of Nursing, University of Nevada-Las Vegas, Las Vegas, NV, USA
| | - Kellie E. Carlyle
- School of Public Health, Virginia Commonwealth University, Richmond, VA, USA
| | - Julie Russo
- School of Public Health, Virginia Commonwealth University, Richmond, VA, USA
| | - Paul B. Perrin
- Department of Data Science, Department of Psychology, University of Virginia, Charlottesville, VA, USA
| |
Collapse
|
15
|
McKeirnan KC, Giruzzi ME, Brand DC, Giruzzi NR, Vaitla K, Dang J. Education for Healthcare Providers: Impact of Academic Detailing on Reducing Misinformation and Strengthening Influenza Vaccine Recommendations. PHARMACY 2024; 12:188. [PMID: 39728853 DOI: 10.3390/pharmacy12060188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2024] [Revised: 12/17/2024] [Accepted: 12/18/2024] [Indexed: 12/28/2024] Open
Abstract
BACKGROUND Recommendations from a trusted healthcare provider have been shown to be the most effective intervention for encouraging patients to be vaccinated. However, providers have reported feeling less prepared to address vaccination questions and having less time to discuss vaccines with patients than before the COVID-19 pandemic. Providers may benefit from a brief update about the available influenza vaccines and vaccination guidelines. Academic detailing is an evidence-based approach for preparing healthcare providers to discuss getting vaccinated with patients. METHODS An academic detailing presentation was developed using influenza statistics, vaccination recommendations, and recent local and national immunization rate data. Academic detailing was conducted with physicians and community pharmacy personnel in Yakima County, Washington, between November 2023 and January 2024. Yakima County is designated as a medically underserved area due to a lack of providers. A pre-detailing survey was conducted to evaluate participant knowledge of current ACIP recommendations and gather opinions about local resident vaccination barriers. A post-detailing survey was conducted to gather participants' opinions about the value of detailing. RESULTS Prior to the training, 73% of providers believed it was important to discuss influenza vaccination with patients, but only 52% felt confident in combating misinformation. Healthcare providers believed misinformation and vaccine hesitancy are the most common barriers for Yakima County patients, but recent survey results showed that online scheduling systems, long wait times, and limited appointment hours were the predominant issues reported locally. Two out of 12 community pharmacy personnel and zero resident physicians correctly named all three preferentially recommended influenza vaccines for patients 65 years and older. Overall, 96% of detailing participants reported that the session was valuable, 87% believed it would help them combat vaccine misinformation, and 65% reported planning to have more conversations with patients about influenza vaccination after participating. CONCLUSION Physicians and community pharmacy immunizers found the influenza vaccines academic detailing to be valuable. Staying up to date on vaccination guidelines can prepare providers to be confident in having informed conversations with patients about getting vaccinated.
Collapse
Affiliation(s)
- Kimberly C McKeirnan
- Pharmacotherapy Department, Washington State University College of Pharmacy and Pharmaceutical Sciences, Yakima, WA 98901, USA
| | - Megan E Giruzzi
- Pharmacotherapy Department, Washington State University College of Pharmacy and Pharmaceutical Sciences, Yakima, WA 98901, USA
| | - Damianne C Brand
- Pharmacotherapy Department, Washington State University College of Pharmacy and Pharmaceutical Sciences, Yakima, WA 98901, USA
| | - Nick R Giruzzi
- Pharmacotherapy Department, Washington State University College of Pharmacy and Pharmaceutical Sciences, Yakima, WA 98901, USA
| | - Kavya Vaitla
- Pharmacotherapy Department, Washington State University College of Pharmacy and Pharmaceutical Sciences, Yakima, WA 98901, USA
| | | |
Collapse
|
16
|
McKeirnan KC, Undeberg MR, Zelenko S, Meratnia G. A Qualitative Analysis of Rural Community Vaccination Barriers During the COVID-19 Pandemic. Vaccines (Basel) 2024; 12:1442. [PMID: 39772102 PMCID: PMC11680148 DOI: 10.3390/vaccines12121442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2024] [Revised: 12/15/2024] [Accepted: 12/17/2024] [Indexed: 01/11/2025] Open
Abstract
BACKGROUND/OBJECTIVES Rural communities in the United States experience increased disparity of care for both general healthcare services and access to routine vaccines. Previous research has indicated a 40% lower vaccination rate in rural communities, as compared to urban counterparts. Having a better understanding regarding factors influencing lower vaccination rates in rural areas could help public health officials prepare for future vaccination efforts. This research sought to gather and evaluate the opinions of people who live and work in rural areas regarding barriers to COVID-19 vaccine uptake. METHODS A semi-structured qualitative key informant interview design was utilized by researchers to gather opinions from university Extension staff in Washington State. Interview transcripts were analyzed using the Theory of Planned Behavior (ToPB) framework to evaluate COVID-19 vaccination-related intentions and motivational factors that the Extension staff observed among rural populations in their communities. RESULTS Twenty-one participants representing 34 out of the 40 Extension offices responded and were interviewed during fall 2023. Using the ToPB constructs, nine barriers were identified. Attitude-related barriers included the following: inherent social distancing in rural location negating vaccine necessity; lack of early vaccine availability in rural locales; concerns regarding ineffectiveness of the vaccine; and inadequate dissemination of vaccine information to non-English language speakers and those with limited access to technology. Subjective norm barriers included the following: perception of exclusion of rural populations' unique needs during design and implementation of vaccine mandates; exertion of social pressures on rural individuals' vaccine uptake decision; and highly visible breakdown in standard trust in core community institutions and leadership. Barriers related to loss of perceived behavioral control included vaccine mandates impacting self-perceived loss of autonomy and limitations in vaccine technology information impacting perception of vaccine safety. CONCLUSIONS By identifying barriers to vaccination in rural communities during the COVID-19 pandemic, future outreach efforts can be designed to improve intention and lead to stronger vaccination uptake.
Collapse
Affiliation(s)
- Kimberly C. McKeirnan
- College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA 99202, USA; (M.R.U.); (S.Z.); (G.M.)
| | | | | | | |
Collapse
|
17
|
Lyeo JS, Liberda EN, Ahmed F, Charania NA, Moriarity RJ, Tsuji LJ, White JP, Zuk AM, Spence ND. Recognising the heterogeneity of Indigenous Peoples during the COVID-19 pandemic: a scoping review across Canada, Australia, New Zealand and the USA. BMJ PUBLIC HEALTH 2024; 2:e001341. [PMID: 40018612 PMCID: PMC11816692 DOI: 10.1136/bmjph-2024-001341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/18/2024] [Accepted: 11/11/2024] [Indexed: 03/01/2025]
Abstract
Objectives The COVID-19 pandemic has had a disproportionate impact on the health of Indigenous Peoples in Canada, Australia, New Zealand and the USA, as reflected in the growing literature. However, Indigenous Peoples are often homogenised, with key differences often overlooked, failing to capture the complexity of issues and may lead to suboptimal public health policy-making. The objective of this review was to assess the extent to which the heterogeneity of the Indigenous Peoples in Canada, Australia, New Zealand and the USA has been reflected in COVID-19 research. Design This study took the form of a scoping review. Data sources Medline, Embase, CINAHL and Web of Science were searched for studies investigating COVID-19 pandemic outcomes among Indigenous Peoples in Canada, Australia, New Zealand and the USA. The search dates included January 2019 to January 2024. Eligibility criteria All citations yielded by this search were subjected to title and abstract screening, full-text review and data extraction. We included original, peer-reviewed research investigating COVID-19-related outcomes among Indigenous Peoples in Canada, Australia, New Zealand or the USA. Data extraction and synthesis Data extraction was conducted as an iterative process, reaching consensus between two of the study authors. All included studies were analysed through a combination of quantitative descriptive summary and qualitative thematic analysis. Results Of the 9795 citations found by the initial search, 428 citations were deemed eligible for inclusion. Of these citations: 72.9% compared Indigenous participants to non-Indigenous participants; 10.0% aggregated Indigenous and non-white participants; and 17.1% provided findings for Indigenous participants exclusively. Conclusions By overlooking the heterogeneity that exists among Indigenous Peoples in Canada, Australia, New Zealand and the USA, researchers and policy-makers run the risk of masking inequities and the unique needs of groups of Indigenous Peoples. This may lead to inefficient policy recommendations and unintentionally perpetuate health disparities during public health crises.
Collapse
Affiliation(s)
- Joonsoo Sean Lyeo
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
| | - Eric N Liberda
- School of Occupational and Public Health, Toronto Metropolitan University, Toronto, Ontario, Canada
| | - Fatima Ahmed
- School of Occupational and Public Health, Toronto Metropolitan University, Toronto, Ontario, Canada
| | - Nadia A Charania
- Department of Public Health, Auckland University of Technology, Auckland, New Zealand
| | - Robert J Moriarity
- School of Occupational and Public Health, Toronto Metropolitan University, Toronto, Ontario, Canada
| | - Leonard J Tsuji
- Department of Health and Society, University of Toronto, Toronto, Ontario, Canada
- Department of Physical and Environmental Sciences, University of Toronto, Toronto, Ontario, Canada
| | - Jerry P White
- Department of Sociology, University of Western Ontario, London, Ontario, Canada
| | - Aleksandra M Zuk
- Department of Physical and Environmental Sciences, University of Toronto, Toronto, Ontario, Canada
- School of Nursing, Queen's University, Kingston, Ontario, Canada
| | - Nicholas D Spence
- Department of Health and Society, University of Toronto, Toronto, Ontario, Canada
- Department of Physical and Environmental Sciences, University of Toronto, Toronto, Ontario, Canada
- Department of Sociology, University of Toronto, Toronto, Ontario, Canada
| |
Collapse
|
18
|
Weerarathna IN, Doelakeh ES, Kiwanuka L, Kumar P, Arora S. Prophylactic and therapeutic vaccine development: advancements and challenges. MOLECULAR BIOMEDICINE 2024; 5:57. [PMID: 39527305 PMCID: PMC11554974 DOI: 10.1186/s43556-024-00222-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2024] [Revised: 10/24/2024] [Accepted: 10/25/2024] [Indexed: 11/16/2024] Open
Abstract
Biomedical research is fundamental in developing preventive and therapeutic vaccines, serving as a cornerstone of global public health. This review explores the key concepts, methodologies, tools, and challenges in the vaccine development landscape, focusing on transitioning from basic biomedical sciences to clinical applications. Foundational disciplines such as virology, immunology, and molecular biology lay the groundwork for vaccine creation, while recent innovations like messenger RNA (mRNA) technology and reverse vaccinology have transformed the field. Additionally, it highlights the role of pharmaceutical advancements in translating lab discoveries into clinical solutions. Techniques like CRISPR-Cas9, genome sequencing, monoclonal antibodies, and computational modeling have significantly enhanced vaccine precision and efficacy, expediting the development of vaccines against infectious diseases. The review also discusses challenges that continue to hinder progress, including stringent regulatory pathways, vaccine hesitancy, and the rapid emergence of new pathogens. These obstacles underscore the need for interdisciplinary collaboration and the adoption of innovative strategies. Integrating personalized medicine, nanotechnology, and artificial intelligence is expected to revolutionize vaccine science further. By embracing these advancements, biomedical research has the potential to overcome existing challenges and usher in a new era of therapeutic and prophylactic vaccines, ultimately improving global health outcomes. This review emphasizes the critical role of vaccines in combating current and future health threats, advocating for continued investment in biomedical science and technology.
Collapse
Affiliation(s)
- Induni Nayodhara Weerarathna
- Department of Biomedical Sciences, School of Allied Health Sciences, Datta Meghe Institute of Higher Education and Research (Deemed to Be University), Wardha, Maharashtra, 442001, India.
| | - Elijah Skarlus Doelakeh
- Department of Anesthesia, School of Allied Health Sciences, Datta Meghe Institute of Higher Education and Research (Deemed to Be University), Wardha, Maharashtra, 442001, India
| | - Lydia Kiwanuka
- Department of Medical Radiology and Imaging Technology, School of Allied Health Sciences, Datta Meghe Institute of Higher Education and Research (Deemed to Be University), Wardha, Maharashtra, 442001, India
| | - Praveen Kumar
- Department of Computer Science and Medical Engineering, FEAT, Datta Meghe Institute of Higher Education and Research (Deemed to Be University), Wardha, Maharashtra, 442001, India
| | - Sanvi Arora
- Faculty of Medicine, Jawaharlal Medical College, Datta Meghe Institute of Higher Education and Research (Deemed to Be University), Wardha, Maharashtra, 442001, India
| |
Collapse
|
19
|
Oliver SE, Wallace M, Twentyman E, Moulia DL, Godfrey M, Link-Gelles R, Meyer S, Fleming-Dutra KE, Hall E, Wolicki J, MacNeil J, Bell BP, Lee GM, Daley MF, Cohn A, Wharton M. Development of COVID-19 vaccine policy - United States, 2020-2023. Vaccine 2024; 42 Suppl 3:125512. [PMID: 38158297 PMCID: PMC11893158 DOI: 10.1016/j.vaccine.2023.12.022] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2023] [Revised: 11/30/2023] [Accepted: 12/05/2023] [Indexed: 01/03/2024]
Abstract
COVID-19 vaccines represent a great scientific and public health achievement in the face of overwhelming pressures from a global pandemic, preventing millions of hospitalizations and deaths due to COVID-19 vaccines in the United States. Over 675 million doses of COVID-19 vaccines have been administered in the United States, and over 80% of the U.S. population has had at least 1 dose of a COVID-19 vaccine. Over the course of the COVID-19 pandemic in the United States, over one million people died from COVID-19, and over six million were hospitalized. It has been estimated that COVID-19 vaccines prevented more than 18 million additional hospitalizations and more than 3 million additional deaths due to COVID-19 in the United States. From the beginning of the COVID-19 pandemic in 2020 through June 2023, ACIP had 35 COVID-19 focused meetings and 24 votes for COVID-19 vaccine recommendations. ACIP had the critical task of rapidly and thoroughly reviewing emerging and evolving data on COVID-19 epidemiology and vaccines, as well as making comprehensive population-based recommendations for vaccine policy and considerations for implementation through a transparent and evidence-based framework. Safe and effective COVID-19 vaccines, recommended through transparent policy discussions with ACIP, remain the best tool we have to prevent serious illness, hospitalization and death from COVID-19.
Collapse
Affiliation(s)
- Sara E Oliver
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
| | - Megan Wallace
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Evelyn Twentyman
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Danielle L Moulia
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Monica Godfrey
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Ruth Link-Gelles
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Sarah Meyer
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Katherine E Fleming-Dutra
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Elisha Hall
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - JoEllen Wolicki
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Jessica MacNeil
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | | | - Grace M Lee
- Stanford University School of Medicine, Stanford, CA, USA
| | - Matthew F Daley
- Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, USA
| | - Amanda Cohn
- National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Melinda Wharton
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| |
Collapse
|
20
|
Zhang Z, Hua Y, Zhou P, Lin S, Li M, Zhang Y, Zhou L, Liao Y, Yang J. Sexual and Gender-Diverse Individuals Face More Health Challenges during COVID-19: A Large-Scale Social Media Analysis with Natural Language Processing. HEALTH DATA SCIENCE 2024; 4:0127. [PMID: 39247070 PMCID: PMC11378377 DOI: 10.34133/hds.0127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/31/2024] [Accepted: 07/25/2024] [Indexed: 09/10/2024]
Abstract
Background: The COVID-19 pandemic has caused a disproportionate impact on the sexual and gender-diverse (SGD) community. Compared with non-SGD populations, their social relations and health status are more vulnerable, whereas public health data regarding SGD are scarce. Methods: To analyze the concerns and health status of SGD individuals, this cohort study leveraged 471,371,477 tweets from 251,455 SGD and 22,644,411 non-SGD users, spanning from 2020 February 1 to 2022 April 30. The outcome measures comprised the distribution and dynamics of COVID-related topics, attitudes toward vaccines, and the prevalence of symptoms. Results: Topic analysis revealed that SGD users engaged more frequently in discussions related to "friends and family" (20.5% vs. 13.1%, P < 0.001) and "wear masks" (10.1% vs. 8.3%, P < 0.001) compared to non-SGD users. Additionally, SGD users exhibited a marked higher proportion of positive sentiment in tweets about vaccines, including Moderna, Pfizer, AstraZeneca, and Johnson & Johnson. Among 102,464 users who self-reported COVID-19 diagnoses, SGD users disclosed significantly higher frequencies of mentioning 61 out of 69 COVID-related symptoms than non-SGD users, encompassing both physical and mental health challenges. Conclusion: The results provide insights into an understanding of the unique needs and experiences of the SGD community during the pandemic, emphasizing the value of social media data in epidemiological and public health research.
Collapse
Affiliation(s)
- Zhiyun Zhang
- Department of Big Data in Health Science School of Public Health, Zhejiang University School of Medicine, Hangzhou, China
| | - Yining Hua
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
- Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA
- Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
| | - Peilin Zhou
- Thrust of Data Science and Analytics, The Hong Kong University of Science and Technology (Guangzhou), Guangzhou, China
| | - Shixu Lin
- Department of Big Data in Health Science School of Public Health, Zhejiang University School of Medicine, Hangzhou, China
| | - Minghui Li
- Department of Big Data in Health Science School of Public Health, Zhejiang University School of Medicine, Hangzhou, China
| | - Yujie Zhang
- Department of Big Data in Health Science School of Public Health, Zhejiang University School of Medicine, Hangzhou, China
| | - Li Zhou
- Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
| | - Yanhui Liao
- Department of Psychiatry, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Jie Yang
- Department of Big Data in Health Science School of Public Health, Zhejiang University School of Medicine, Hangzhou, China
| |
Collapse
|
21
|
Khedr S, Hong J, Forter-Chee-A-Tow N, Cygiel G, Heffernan DS, Lee BE, Chao SY. Reporting Minority Race and Ethnicity in Cardiovascular and Thoracic Journals. J Surg Res 2024; 301:352-358. [PMID: 39024714 DOI: 10.1016/j.jss.2024.06.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2024] [Revised: 05/25/2024] [Accepted: 06/24/2024] [Indexed: 07/20/2024]
Abstract
INTRODUCTION Currently, there is no mandatory standard for reporting race and ethnicity in medical journals, presenting significant barriers to studying disparities in medical outcomes. We seek to investigate whether greater recent awareness of diversity and inclusion reflects in reporting of race and ethnicity by peer-reviewed cardiothoracic articles. METHODS Pubmed was queried for clinical outcomes articles published from January 2017 to June 2023 in the Journal of Thoracic and Cardiovascular Surgery, Annals of Thoracic Surgery, Journal of Heart and Lung Transplantation, and CHEST Journal. Basic science, translational studies, and international studies were excluded. SAS Studio was used for statistical analysis. RESULTS 817 papers were reviewed, 378 reported race/ethnicity with 354 (93%) reporting White, 267 (71%) reporting Black, 128 (34%) reporting Hispanic, and 119 (31%) reporting Asian. Over 8-y, there were no statistically significant changes in percent of articles that included White (odds ratio 0.808 95% confidence interval [0.624-1.047], P = 0.1068), Black (1.125 [0.984-1.288], P = 0.0857), or Asian (1.096 [0.960-1.250], P = 0.1751) groups. Hispanics were more likely to be reported in recent years (1.147 [1.006-1.307], P = 0.0397). Subset analysis was performed on cardiac (n = 157) and thoracic articles (n = 157) with no significant trends for race reporting in these subsets. CONCLUSIONS Minorities remain underrepresented in reported patient populations in peer-reviewed cardiothoracic journals. Future efforts should prioritize accurately representing these populations in the literature. Inaccurate data and exclusion of minority populations can contribute to disparities observed in overall outcomes.
Collapse
Affiliation(s)
- Shahenda Khedr
- Department of General Surgery, New York Presbyterian-Queens, Queens, New York.
| | - Julie Hong
- Department of General Surgery, New York Presbyterian-Queens, Queens, New York
| | | | - Gala Cygiel
- Department of General Surgery, New York Presbyterian-Queens, Queens, New York
| | | | - Benjamin E Lee
- Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York
| | - Steven Y Chao
- Department of General Surgery, New York Presbyterian-Queens, Queens, New York; Department of Surgery, Weill Cornell Medicine, New York, New York
| |
Collapse
|
22
|
Ganczak M, Kalinowski P, Twardowski P, Osicka DA, Pasek O, Duda-Duma Ł, Vervoort JPM, Edelstein M, Kowalska M. "Why would we?" A qualitative study on COVID-19 vaccination decision making among Ukrainian economic female migrants in Poland. Front Public Health 2024; 12:1380627. [PMID: 39193195 PMCID: PMC11347284 DOI: 10.3389/fpubh.2024.1380627] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2024] [Accepted: 08/01/2024] [Indexed: 08/29/2024] Open
Abstract
Background Ukraine has one of the lowest COVID-19 vaccination rates in Europe. This may pose a significant epidemiological risk in the context of the refugee crisis and the fact that, since 2020, SARS-CoV-2 has been spreading and changing globally. Objective To evaluate determinants of vaccination decision making among Ukrainian female migrants (UFMs). Methods A qualitative study with 45 UFMs was conducted between December 2021 and January 2022. UFMs, from 2 Polish provinces, differing in age, education and length of stay were invited with the use of the snowball technique. Using a semi-structured topic guide, eight focus groups were conducted in person, recorded and transcribed. Thematic, qualitative analysis was made; key themes which emerged from the data (with the help of the Working Group Determinants of Vaccine Hesitancy Matrix), were related to contextual, individual/group and contextual vaccine/vaccination-specific influences. Results Mothers were found to be playing a crucial role in children and adolescent COVID-19 vaccine decision-making process. Universal trust in the Polish healthcare system and vaccination procedures, employer requirements and willingness to preserve jobs, desire to get back to normal and social influences were paramount prerequisites to let UFMs make a decision to get vaccinated. However, COVID-19 vaccines also faced backlash among UFMs. Negative experiences with vaccines provided in Ukraine, doubts about the rapid vaccine development, combined with lack of confidence in vaccine safety, specifically regarding child vaccination, might have a bearing on UFMs' decision about declining COVID-19 vaccine while on migration. Discrimination through HCWs during vaccination visits was also reported. Corrupted Ukrainian healthcare system, which facilitates proof forgery regarding vaccination certificates, could act as a negative influencer of UFMs' vaccine decision-making. Conclusion The results provide the novel information, expressed in economic UFMs' own words. Findings show that influencers of the decision-making process regarding the COVID-19 vaccination are complex and polarized; elements of hesitancy may persist after migration. Any continuation of UFMs' vaccination with COVID-19 vaccine should be subject to designing accessible information to address modifiable demotivators of the vaccine decision-making process identified in this study.
Collapse
Affiliation(s)
- Maria Ganczak
- Department of Infectious Diseases, Collegium Medicum, University of Zielona Góra, Zielona Góra, Poland
| | - Pawel Kalinowski
- Department of Hygiene and Epidemiology, Medical University of Lublin, Lublin, Poland
| | - Piotr Twardowski
- Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
| | - Dominika A. Osicka
- Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
| | - Oskar Pasek
- Student Research Group, Collegium Medicum, University of Zielona Góra, Zielona Góra, Poland
| | - Łukasz Duda-Duma
- Student Research Group, Collegium Medicum, University of Zielona Góra, Zielona Góra, Poland
| | - Johanna P. M. Vervoort
- Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
| | | | - Marta Kowalska
- Department of Hygiene and Epidemiology, Medical University of Lublin, Lublin, Poland
| |
Collapse
|
23
|
Maar M, Bourdon C, Berti J, Bisaillon E, Boesch L, Boston A, Chapdelaine J, Humphrey A, Kumar S, Maar-Jackson B, Martell R, Naokwegijig B, Preet Kaur D, Rice S, Rickaby B, Sutherland M, Reade M. Creating a Culturally Safe Online Data Collection Instrument to Measure Vaccine Confidence Among Indigenous Youth: Indigenous Consensus Method. JMIR Form Res 2024; 8:e52884. [PMID: 39133917 PMCID: PMC11347907 DOI: 10.2196/52884] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2023] [Revised: 04/19/2024] [Accepted: 05/10/2024] [Indexed: 08/30/2024] Open
Abstract
BACKGROUND Participating in surveys can shape the perception of participants related to the study topic. Administering a vaccine hesitancy questionnaire can have negative impacts on participants' vaccine confidence. This is particularly true for online and cross-cultural data collection because culturally safe health education to correct misinformation is typically not provided after the administration of an electronic survey. OBJECTIVE To create a culturally safe, online, COVID-19 vaccine confidence survey for Indigenous youth designed to collect authentic, culturally relevant data of their vaccine experiences, with a low risk of contributing to further vaccine confusion among participants. METHODS Using the Aboriginal Telehealth Knowledge Circle consensus method, a team of academics, health care providers, policy makers, and community partners reviewed COVID-19 vaccine hesitancy surveys used in public health research, analyzed potential risks, and created a framework for electronic Indigenous vaccine confidence surveys as well as survey items. RESULTS The framework for safer online survey items is based on 2 principles, a first do-no-harm approach and applying a strengths-based lens. Relevant survey domains identified in the process include sociodemographic information, participants' connection to their community, preferred sources for health information, vaccination uptake among family members and peers, as well as personal attitudes toward vaccines. A total of 44 survey items were developed, including 5 open-ended items to improve the authenticity of the data and the analysis of the experiences of Indigenous youth. CONCLUSIONS Using an Indigenous consensus method, we have developed an online COVID-19 vaccine confidence survey with culturally relevant domains and reduced the risk of amplifying misinformation and negative impacts on vaccine confidence among Indigenous participants. Our approach can be adapted to other online survey development in collaboration with Indigenous communities.
Collapse
Affiliation(s)
- Marion Maar
- Human Sciences Division, Northern Ontario School of Medicine (NOSM) University, Sudbury, ON, Canada
| | - Caleigh Bourdon
- Undergraduate Medical Education, Northern Ontario School of Medicine (NOSM) University, Sudbury, ON, Canada
| | - Joahnna Berti
- Debajehmujig Storytellers, Debajehmujig Theatre Group, Manitowaning, ON, Canada
| | - Emma Bisaillon
- Interdisciplinary Health, Laurentian University, Sudbury, ON, Canada
| | - Lisa Boesch
- Human Sciences Division, Northern Ontario School of Medicine (NOSM) University, Sudbury, ON, Canada
| | - Alicia Boston
- Public Health Sudbury & Districts, Sudbury, ON, Canada
| | | | | | - Sandeep Kumar
- Postgraduate Medical Education, Northern Ontario School of Medicine (NOSM) University, Thunder Bay, ON, Canada
| | | | - Robert Martell
- Interdisciplinary Health, Laurentian University, Sudbury, ON, Canada
| | - Bruce Naokwegijig
- Debajehmujig Storytellers, Debajehmujig Theatre Group, Manitowaning, ON, Canada
| | - Davinder Preet Kaur
- Postgraduate Medical Education, Northern Ontario School of Medicine (NOSM) University, Thunder Bay, ON, Canada
| | - Sarah Rice
- Public Health Sudbury & Districts, Sudbury, ON, Canada
| | - Barbara Rickaby
- School of Rural and Northern Health, Laurentian University, Sudbury, ON, Canada
| | | | - Maurianne Reade
- Clinical Sciences Divison, Northern Ontario School of Medicine (NOSM) University, Sudbury, ON, Canada
| |
Collapse
|
24
|
Fernandez JR, Richmond J, Strassle PD, Cunningham-Erves J, Forde AT. Motivators and Barriers to COVID-19 Vaccination Intentions Across U.S. County-Level Barriers in the COVID-19 Vaccine Coverage Index. J Racial Ethn Health Disparities 2024:10.1007/s40615-024-02096-9. [PMID: 39093376 PMCID: PMC11866401 DOI: 10.1007/s40615-024-02096-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2024] [Revised: 07/07/2024] [Accepted: 07/10/2024] [Indexed: 08/04/2024]
Abstract
BACKGROUND County-level barriers (sociodemographic barriers, limited healthcare system resources, healthcare accessibility barriers, irregular healthcare seeking behaviors, low vaccination history) may impact individuals' reasons for receiving the COVID-19 vaccine. METHODS This study linked data from REACH-US (Race-Related Experiences Associated with COVID-19 and Health in the United States), a nationally representative, online survey of 5475 adults living in the U.S (January-March 2021) to county-level barriers in the COVID-19 Vaccine Coverage Index. County-level vaccination barriers were measured using the COVID-19 Vaccine Coverage Index. Participants reported why they would or would not receive the COVID-19 vaccine in an open-ended item and their responses were coded using thematic analysis. Descriptive statistics and chi-square tests assessed whether reasons for COVID-19 vaccination intentions varied by county-level barriers and whether these distributions varied across racial/ethnic groups. RESULTS Thematic analysis revealed twelve themes in participants' reasons why they would or would not receive the COVID-19 vaccine. Themes of societal responsibility (9.8% versus 7.7%), desire to return to normal (8.1% versus 4.7%), and trust in science/healthcare/government (7.7% versus 5.1%) were more frequently reported in counties with low/medium barriers (versus high/very high) (p-values < 0.05). Concerns of COVID-19 vaccine side effects/safety/development (25.3% versus 27.9%) and concerns of access/costs/availability/convenience (1.9% versus 3.6%) were less frequently reported in counties with low/medium barriers (versus high/very high) (p-values < 0.05). Trends in the prevalence of these themes varied across racial/ethnic groups (p-values < 0.05). CONCLUSIONS Future pandemic responses should consider potential ways county-level barriers shape reasons for COVID-19 vaccination.
Collapse
Affiliation(s)
- Jessica R Fernandez
- Division of Intramural Research, National Institute On Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA
| | - Jennifer Richmond
- Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, NC, USA
| | - Paula D Strassle
- Division of Intramural Research, National Institute On Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA
| | | | - Allana T Forde
- Division of Intramural Research, National Institute On Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA.
| |
Collapse
|
25
|
Avorgbedor F, Gondwe KW, Aljarrah A, Bankole AO. COVID-19 Vaccine Decision-Making Among Black Pregnant and Postpartum Women. J Racial Ethn Health Disparities 2024; 11:2073-2082. [PMID: 37335424 PMCID: PMC12045292 DOI: 10.1007/s40615-023-01675-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2023] [Revised: 05/31/2023] [Accepted: 06/05/2023] [Indexed: 06/21/2023]
Abstract
INTRODUCTION The history of biomedical research is marred by racially discriminatory and abusive practices that impacted Black/African Americans. Medical racism impacts the trust and utilization of new medical interventions, such as the COVID-19 vaccine. This study aimed to understand Black pregnant and postpartum women's perspectives and decision-making about the COVID-19 vaccine. METHODS We used a qualitative descriptive design and recruited 23 pregnant and postpartum Black women aged 18 years and above. Data was collected using a semi-structured interview guide. Data were analyzed using content analysis. FINDINGS The participants described factors influencing their decision to receive or not receive the COVID-19 vaccines. These factors included individual, cultural, ethnicity, religious, and family-related factors (individual-personal beliefs influenced decisions about the vaccine; ethnicity, culture, and religion influenced vaccine decision-making; group-family and friends played a role in decision-making), vaccine or vaccination-related issues (concerns about vaccination and pregnancy outcomes and mistrust in the vaccine information), and contextual influence (sources of vaccine information influenced decision-making and healthcare providers influenced decision-making). CONCLUSION Understanding the vaccine decision-making process of underserved populations likely to decline vaccination due to pregnancy, postpartum, and breastfeeding status will help design tailored interventions to improve vaccine acceptance in minority communities, especially for pregnant and postpartum women.
Collapse
Affiliation(s)
- Forgive Avorgbedor
- School of Nursing, University of North Carolina Greensboro, Greensboro, NC, USA.
| | | | - Ahmad Aljarrah
- School of Nursing, University of North Carolina Greensboro, Greensboro, NC, USA
| | | |
Collapse
|
26
|
Mercado M, Lopez G, Ignacio M, Ayers S, Carver A, Hamm K, Wolfersteig W, Oesterle S. Hesitant or Confident: A Qualitative Study Examining Latinos' Perceptions of COVID-19 Vaccines in Arizona. HEALTH EDUCATION & BEHAVIOR 2024; 51:512-520. [PMID: 38804533 DOI: 10.1177/10901981241255619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/29/2024]
Abstract
This study aimed to understand vaccine hesitancy and confidence toward the COVID-19 vaccines among Latino adults in Arizona. Latinos (n = 71) aged 18 years or older who resided in Arizona participated in 14 focus groups between February and June 2021. Theoretical thematic analysis was used to examine drivers of these two behaviors, namely, vaccine hesitancy and confidence toward the COVID-19 vaccines, using the COM-B model, comprising capability, opportunity, and motivation factors that generate a behavior. Vaccine hesitancy stemmed from the need for vaccine information (capability factor) and fear of the vaccines, religious beliefs, and perceived barriers stemming from government mistrust (motivation factors). Vaccine confidence arose from trust in science and doctors (capability factor), and a fear of getting sick, protection against COVID-19, getting vaccinated as a civic duty, and a desire to return to normal life (motivation factors). The influence of opportunity factors, such as having access to vaccinations, were not discussed as contributing to vaccine confidence or hesitancy. As predicted by the COM-B model, factors reflecting capabilities and motivations contributed to vaccine hesitancy and confidence, all of which need to be considered in public health messaging. These factors can be targeted to facilitate efforts to promote vaccine uptake and reduce the spread of COVID-19.
Collapse
Affiliation(s)
- Micaela Mercado
- Southwest Interdisciplinary Research Center, School of Social Work, Arizona State University, Phoenix, AZ, USA
| | - Gilberto Lopez
- School of Transboarder Studies, Arizona State University, Phoenix, AZ, USA
| | - Matt Ignacio
- Southwest Interdisciplinary Research Center, School of Social Work, Arizona State University, Phoenix, AZ, USA
| | - Stephanie Ayers
- Southwest Interdisciplinary Research Center, School of Social Work, Arizona State University, Phoenix, AZ, USA
| | - Ann Carver
- Southwest Interdisciplinary Research Center, School of Social Work, Arizona State University, Phoenix, AZ, USA
| | - Kathryn Hamm
- Southwest Interdisciplinary Research Center, School of Social Work, Arizona State University, Phoenix, AZ, USA
| | - Wendy Wolfersteig
- Southwest Interdisciplinary Research Center, School of Social Work, Arizona State University, Phoenix, AZ, USA
| | - Sabrina Oesterle
- Southwest Interdisciplinary Research Center, School of Social Work, Arizona State University, Phoenix, AZ, USA
| |
Collapse
|
27
|
Chanchlani R, Shah BR, Bangdiwala SI, de Souza RJ, Luo J, Bolotin S, Bowdish DME, Desai D, Everett K, Lear SA, Loeb M, Punthakee Z, Sherifali D, Wahi G, Anand SS. COVID-19 vaccine effectiveness among South Asians in Canada. PLOS GLOBAL PUBLIC HEALTH 2024; 4:e0003490. [PMID: 39088444 PMCID: PMC11293718 DOI: 10.1371/journal.pgph.0003490] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/20/2023] [Accepted: 06/24/2024] [Indexed: 08/03/2024]
Abstract
We evaluated the effectiveness of COVID-19 vaccines among South Asians living in Ontario, Canada compared to non-South Asians and compared the odds of symptomatic COVID-19 infection and related hospitalizations and deaths among non-vaccinated South Asians and non-South Asians. This was a test negative design study conducted in Ontario, Canada between December 14, 2020 and November 15, 2021. All eligible individuals >18 years with symptoms of COVID-19 were subdivided by ethnicity (South Asian vs other) and vaccination status (vaccinated versus not). The primary outcome was vaccine effectiveness as defined by COVID-19 infections, hospitalizations, and deaths, and secondary outcome was the odds of COVID-19 infections, hospitalizations, and death comparing non-vaccinated South Asians to non-vaccinated non-South Asians. 883,155 individuals were included. Among South Asians, two doses of COVID-19 vaccine prevented 93.8% (95% CI 93.2, 94.4) of COVID-19 infections and 97.5% (95% CI 95.2, 98.6) of hospitalizations and deaths. Among non-South Asians, vaccines prevented 86.6% (CI 86.3, 86.9) of COVID-19 infections and 93.1% (CI 92.2, 93.8) of hospitalizations and deaths. Non-vaccinated South Asians had higher odds of symptomatic SARS-CoV-2 infection compared to non-vaccinated non-South Asians (OR 2.35, 95% CI 2.3, 2.4), regardless of their immigration status. COVID-19 vaccines are effective in preventing infections, hospitalizations and deaths among South Asians living in Canada. The observation that non-vaccinated South Asians have higher odds of symptomatic COVID-19 infection warrants further investigation.
Collapse
Affiliation(s)
- Rahul Chanchlani
- Division of Pediatric Nephrology, Department of Pediatrics, McMaster Children’s Hospital, Hamilton, Ontario, Canada
- ICES, Toronto, Ontario, Canada
- Chanchlani Research Centre, McMaster University, Hamilton, Ontario, Canada
- Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
| | - Baiju R. Shah
- ICES, Toronto, Ontario, Canada
- Department of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Shrikant I. Bangdiwala
- Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
| | - Russell J. de Souza
- Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
| | - Jin Luo
- ICES, Toronto, Ontario, Canada
| | - Shelly Bolotin
- Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
- Department of Laboratory Medicine and Pathobiology University of Toronto, Toronto, Ontario, Canada
- Public Health Ontario, Toronto, Ontario, Canada
| | - Dawn M. E. Bowdish
- Firestone Institute for Respiratory Health, St. Joseph’s Healthcare, St. Joseph’s Healthcare, Hamilton, Ontario, Canada
- Department of Medicine, McMaster University, Hamilton, Ontario, Canada
| | - Dipika Desai
- Chanchlani Research Centre, McMaster University, Hamilton, Ontario, Canada
- Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
| | | | - Scott A. Lear
- Simon Fraser University, Burnaby, British Columbia, Canada
| | - Mark Loeb
- Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
- Department of Pathology and Molecular Medicine, Hamilton, Ontario, Canada
| | - Zubin Punthakee
- Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
- Department of Medicine, McMaster University, Hamilton, Ontario, Canada
| | - Diana Sherifali
- Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
| | - Gita Wahi
- Chanchlani Research Centre, McMaster University, Hamilton, Ontario, Canada
- Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada
| | - Sonia S. Anand
- Chanchlani Research Centre, McMaster University, Hamilton, Ontario, Canada
- Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
- Department of Medicine, McMaster University, Hamilton, Ontario, Canada
| |
Collapse
|
28
|
Driedger SM, Maier R, Capurro G, Jardine C, Tustin J, Chartrand F, Sanguins J, Kloss O. "There's a little bit of mistrust": Red River Métis experiences of the H1N1 and COVID-19 pandemics. RISK ANALYSIS : AN OFFICIAL PUBLICATION OF THE SOCIETY FOR RISK ANALYSIS 2024; 44:1770-1787. [PMID: 38286593 DOI: 10.1111/risa.14274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/07/2023] [Revised: 11/24/2023] [Accepted: 12/28/2023] [Indexed: 01/31/2024]
Abstract
We examined the perspectives of the Red River Métis citizens in Manitoba, Canada, during the H1N1 and COVID-19 pandemics and how they interpreted the communication of government/health authorities' risk management decisions. For Indigenous populations, pandemic response strategies play out within the context of ongoing colonial relationships with government institutions characterized by significant distrust. A crucial difference between the two pandemics was that the Métis in Manitoba were prioritized for early vaccine access during H1N1 but not for COVID-19. Data collection involved 17 focus groups with Métis citizens following the H1N1 outbreak and 17 focus groups during the COVID-19 pandemic. Métis prioritization during H1N1 was met with some apprehension and fear that Indigenous Peoples were vaccine-safety test subjects before population-wide distribution occurred. By contrast, as one of Canada's three recognized Indigenous nations, the non-prioritization of the Métis during COVID-19 was viewed as an egregious sign of disrespect and indifference. Our research demonstrates that both reactions were situated within claims that the government does not care about the Métis, referencing past and ongoing colonial motivations. Government and health institutions must anticipate this overarching colonial context when making and communicating risk management decisions with Indigenous Peoples. In this vein, government authorities must work toward a praxis of decolonization in these relationships, including, for example, working in partnership with Indigenous nations to engage in collaborative risk mitigation and communication that meets the unique needs of Indigenous populations and limits the potential for less benign-though understandable-interpretations.
Collapse
Affiliation(s)
- S Michelle Driedger
- Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
| | - Ryan Maier
- Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
| | - Gabriela Capurro
- Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
| | - Cindy Jardine
- Faculty of Health Sciences, University of the Fraser Valley, Chilliwack, British Columbia, Canada
| | - Jordan Tustin
- School of Occupational and Public Health, Toronto Metropolitan University, Toronto, Ontario, Canada
| | - Frances Chartrand
- Health & Wellness Department, Manitoba Métis Federation, Winnipeg, Manitoba, Canada
| | - Julianne Sanguins
- Health & Wellness Department, Manitoba Métis Federation, Winnipeg, Manitoba, Canada
| | - Olena Kloss
- Health & Wellness Department, Manitoba Métis Federation, Winnipeg, Manitoba, Canada
| |
Collapse
|
29
|
Kaczynski M, Vassilopoulos A, Vassilopoulos S, Sisti A, Benitez G, Tran QL, Mylona EK, Shehadeh F, Rogers R, Mylonakis E. Temporal trends and characteristics associated with racial, ethnic, and sex representation in COVID-19 clinical trials: A systematic review and meta-analysis. Contemp Clin Trials 2024; 143:107578. [PMID: 38789079 DOI: 10.1016/j.cct.2024.107578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2023] [Revised: 05/05/2024] [Accepted: 05/21/2024] [Indexed: 05/26/2024]
Abstract
BACKGROUND Early in the pandemic, extensive attention was cast on limited inclusion of historically underrepresented patient populations in COVID-19 clinical trials. How diverse representation improved following these initial reports remains unclear. METHODS PubMed, Embase and the Cochrane Library were searched (through April 2024) for US-based COVID-19 trials. Utilizing random-effects, we compared expected proportions of trial participants from racial and ethnic groups and of female sex between trials enrolling primarily in 2020 versus primarily 2021-2022. Meta-regression was performed to assess associations between trial characteristics and group representation. RESULTS We retrieved 157 studies comprising 198,012 participants. White (2020: 63.1% [95% CI, 60.8%-67.3%]; 2021-2022: 73.8% [95% CI, 71.5%-76.0%]) and female representation (2020: 46.1% [95% CI, 44.7%-47.4%)]; 2021-2022: 51.1% [95% CI, 49.3%-52.8%) increased across enrollment periods. Industry-sponsored trials were associated with higher White (coefficient, 0.10 [95% CI, 0.03-0.18]) and Hispanic or Latinx representation (coefficient, 0.16 [95% CI, 0.08-0.25]) and lower Asian (coefficient, -0.03 [95% CI, -0.06- -0.003]) and female representation (coefficient, -0.03 [95% CI, -0.07- -0.002]). Outpatient trials were associated with higher White (coefficient, 0.20 [95% CI, 0.13-0.26]) and female representation (coefficient, 0.16 [95% CI, 0.13-0.18]), and lower Black representation (coefficient, -0.10 [95% CI, -0.10- -0.08]). CONCLUSIONS Despite improved female representation in COVID-19 trials over time, there was no clear increase in non-White representation. Trial characteristics such as primary sponsor, clinical setting, and intervention type correlate with representation of specific demographic groups and should be considered in future efforts to improve participant diversity.
Collapse
Affiliation(s)
- Matthew Kaczynski
- Warren Alpert Medical School at Brown University, Providence, RI, USA
| | - Athanasios Vassilopoulos
- Department of Internal Medicine, Warren Alpert Medical School at Brown University, Providence, RI, USA
| | - Stephanos Vassilopoulos
- Department of Internal Medicine, Warren Alpert Medical School at Brown University, Providence, RI, USA
| | - Anthony Sisti
- Department of Biostatistics, Brown University School of Public Health, Providence, RI, USA
| | - Gregorio Benitez
- Infectious Diseases Division, Warren Alpert Medical School at Brown University, Providence, RI, USA
| | - Quynh-Lam Tran
- Geisel School of Medicine at Dartmouth University, Hanover, NH, USA
| | - Evangelia K Mylona
- Department of Medicine, Houston Methodist Research Institute, Houston, TX, USA
| | - Fadi Shehadeh
- Department of Medicine, Houston Methodist Research Institute, Houston, TX, USA; School of Electrical and Computer Engineering, National Technical University of Athens, Athens, Greece
| | - Ralph Rogers
- Infectious Diseases Division, Warren Alpert Medical School at Brown University, Providence, RI, USA
| | - Eleftherios Mylonakis
- Infectious Diseases Division, Warren Alpert Medical School at Brown University, Providence, RI, USA; Department of Medicine, Houston Methodist Hospital, Houston, TX, USA.
| |
Collapse
|
30
|
McKeirnan K, Brand D, Giruzzi M, Vaitla K, Giruzzi N, Krebill-Prather R, Dang J. Evaluating Factors That Influence Influenza Vaccination Uptake among Pregnant People in a Medically Underserved Area in Washington State. Vaccines (Basel) 2024; 12:768. [PMID: 39066406 PMCID: PMC11281722 DOI: 10.3390/vaccines12070768] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2024] [Revised: 07/05/2024] [Accepted: 07/11/2024] [Indexed: 07/28/2024] Open
Abstract
INTRODUCTION Despite substantial evidence demonstrating the effectiveness of influenza vaccines, only 38.6% of the adult United States population received an influenza vaccine during the 2023-2024 flu season. Vaccination rates are typically lower among U.S. minority groups, and in 2022, pregnant persons from U.S. minority racial and ethnic groups showed a decrease in influenza vaccine coverage. METHODS A survey was conducted with residents of Yakima County, Washington, which is home to one of the state's largest percentages of people who identify as Hispanic or Latino/a. The objective was to evaluate the uptake of influenza vaccine among pregnant persons. Surveys were sent to a random sample of 3000 residential mailing addresses. Of the 500 respondents, 244 (52.1%) reported that they had been pregnant, with those identifying as Hispanic or Latino/a constituting 23.8% of this total. Only 62 (26.2%) reported being immunized against influenza during pregnancy. Respondents who were immunized against influenza chose to be vaccinated to protect themselves from the flu (85.5%, n = 53); because a healthcare provider recommended getting vaccinated (85.5%, n = 53); to protect the baby from the flu (82.3%, n = 51); because it was available for free or low cost (62.9%, n = 39); and because vaccination was convenient (54.8%, n = 34). Qualitative evaluation identified that participants who were not vaccinated against influenza during pregnancy believed the vaccination was not needed, was not recommended by a healthcare provider, was difficult to access, they were against vaccination in general, or they were concerned about the safety and ingredients of the vaccine. CONCLUSION Barriers to vaccination identified in this study included vaccine distrust, lack of awareness, and concerns about vaccine efficacy and safety. Healthcare providers can help address these concerns by providing education and recommendations about the importance of influenza vaccination during pregnancy.
Collapse
Affiliation(s)
- Kimberly McKeirnan
- Pharmacotherapy Department, Spokane Campus, Washington State University, Spokane, WA 99202, USA;
| | - Damianne Brand
- Pharmacotherapy Department, Yakima Campus, Washington State University, Yakima, WA 98901, USA; (D.B.); (M.G.); (N.G.)
| | - Megan Giruzzi
- Pharmacotherapy Department, Yakima Campus, Washington State University, Yakima, WA 98901, USA; (D.B.); (M.G.); (N.G.)
| | - Kavya Vaitla
- Pharmacotherapy Department, Spokane Campus, Washington State University, Spokane, WA 99202, USA;
| | - Nick Giruzzi
- Pharmacotherapy Department, Yakima Campus, Washington State University, Yakima, WA 98901, USA; (D.B.); (M.G.); (N.G.)
| | - Rose Krebill-Prather
- Social and Economic Sciences Research Center, Pullman Campus, Washington State University, Pullman, WA 99164, USA;
| | | |
Collapse
|
31
|
Prieto-Campo Á, Vázquez-Cancela O, Roque F, Herdeiro MT, Figueiras A, Zapata-Cachafeiro M. Unmasking vaccine hesitancy and refusal: a deep dive into Anti-vaxxer perspectives on COVID-19 in Spain. BMC Public Health 2024; 24:1751. [PMID: 38951819 PMCID: PMC11218155 DOI: 10.1186/s12889-024-18864-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2024] [Accepted: 05/16/2024] [Indexed: 07/03/2024] Open
Abstract
BACKGROUND At the time of the emergence of COVID-19, denialist and anti-vaccine groups have also emerged and are shaking public confidence in vaccination. METHODS A qualitative study was conducted using online focus groups. Participants had not received any doses of vaccination against the disease. A total of five focus group sessions were conducted with 28 participants. They were recruited by snowball sampling and by convenience sampling. RESULTS The two major topics mentioned by the participants were adverse effects and information. The adverse effects described were severe and included sudden death. In the case of information, participants reported: (1) consultation of websites on which scientists posted anti-vaccination content; and (2) distrust. CONCLUSIONS At a time when anti-vaccine groups pose a major challenge to public health in general, and to COVID-19 vaccination campaigns in particular, this study is a first step towards gaining deeper insight into the factors that lead to COVID-19 vaccine refusal.
Collapse
Affiliation(s)
- Ángela Prieto-Campo
- Department of Public Health, Faculty of Pharmacy, University of Santiago de Compostela, Santiago de Compostela, A Coruña, Spain.
| | - Olalla Vázquez-Cancela
- Department of Public Health, Faculty of Pharmacy, University of Santiago de Compostela, Santiago de Compostela, A Coruña, Spain
- Department of Preventive Medicine, Santiago de Compostela University Teaching Hospital, Santiago de Compostela, A Coruña, Spain
| | - Fátima Roque
- Research Unit for Inland Development (Unidade para o Desenvolvimento do Interior/UDI-IPG), Polytechnic of Guarda, Guarda, Portugal
- Health Sciences Research Centre (Centro de Investigação em Ciências da Saúde/CICS-UBI), University of Beira Interior, Covilhã, Portugal
- School of Health Sciences (Escola Superior de Saúde/ESS), Guarda Polytechnic Institute, Guarda, Portugal
| | - Maria Teresa Herdeiro
- Department of Medical Sciences, Institute of Biomedicine (iBiMED), University of Aveiro, Aveiro, Portugal
| | - Adolfo Figueiras
- Department of Public Health, Faculty of Pharmacy, University of Santiago de Compostela, Santiago de Compostela, A Coruña, Spain
- Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública/CIBERESP), Carlos III Institute of Health, Madrid, Spain
- Health Research Institute of Santiago de Compostela (Instituto de Investigación Sanitaria de Santiago de Compostela/IDIS), A Coruña, Spain
| | - Maruxa Zapata-Cachafeiro
- Department of Public Health, Faculty of Pharmacy, University of Santiago de Compostela, Santiago de Compostela, A Coruña, Spain
- Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública/CIBERESP), Carlos III Institute of Health, Madrid, Spain
- Health Research Institute of Santiago de Compostela (Instituto de Investigación Sanitaria de Santiago de Compostela/IDIS), A Coruña, Spain
| |
Collapse
|
32
|
Üsküp DK, Castellon-Lopez YM, Jolayemi O, Branch CA, Adeyiga O, Shoptaw S. Racial (In)Equity in South Los Angeles-Community Centered Experiences with COVID-19 Syndemics. Health Equity 2024; 8:446-454. [PMID: 39011070 PMCID: PMC11249122 DOI: 10.1089/heq.2023.0188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/05/2024] [Indexed: 07/17/2024] Open
Abstract
Objectives To analyze community experiences involving COVID-19 vaccination access and equity in Black and Latina/o/x communities within South Los Angeles, using a socioecological framework. Methods We conducted four virtual focus groups (n = 33 total participants) in 2021, with Black and Latina/o/x community members, community leaders, and community-based providers in South Los Angeles, a region highly impacted by the COVID-19 pandemic. We used a grounded theory approach to guide the analysis and generate data shaped by participant perspectives. Results Participants across groups consistently emphasized medical mistrust, fear/skepticism, misinformation, accessibility, and feelings of pressure and blame as factors influencing COVID-19 vaccination decisions. The need to address pandemic-related socioeconomic hardships in underresourced communities was equally highlighted. Conclusions Findings show that building trust, providing tailored information, and continued investment into diversity and equity initiatives can support Black and Latino/a/x communities in making informed health decisions. Community-centered support services should address the economic, social, and structural impact of the pandemic on vulnerable communities. Furthermore, public health and policy efforts must prioritize funding to equip social and health care systems with infrastructure investment in racial and ethnic minority communities.
Collapse
Affiliation(s)
- Dilara K. Üsküp
- Department of Family Medicine, UCLA David Geffen School of Medicine, University of California, Los Angeles, California, USA
- Department of Internal Medicine, Charles R. Drew University of Medicine, and Science, Los Angeles, California, USA
| | | | - Oluwadamilola Jolayemi
- Department of Family Medicine, UCLA David Geffen School of Medicine, University of California, Los Angeles, California, USA
| | - Cheryl A. Branch
- The Community Response System of South Los Angeles (CRSSLA), Los Angeles, California, USA
| | - Oladunni Adeyiga
- Department of Medicine, Division of Infectious Diseases, UCLA David Geffen School of Medicine, Los Angeles, California, USA
| | - Steve Shoptaw
- Department of Family Medicine, UCLA David Geffen School of Medicine, University of California, Los Angeles, California, USA
| |
Collapse
|
33
|
Nawaz S, Moon KJ, Anagbonu F, Trinh A, Escobedo L, Montiel GI. Evaluation of the COVID-19 Vaccination Campaign ¡Ándale! ¿Qué Esperas? in Latinx Communities in California, June 2021-May 2022. Public Health Rep 2024; 139:44S-52S. [PMID: 37957827 PMCID: PMC11339681 DOI: 10.1177/00333549231204043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2023] Open
Abstract
OBJECTIVES The 12-month vaccination campaign ¡Ándale! ¿Qué Esperas? was launched to increase COVID-19 vaccination rates in Latinx populations in California by expanding community outreach. The objectives of this evaluation were to (1) determine predictors of vaccination rates and (2) identify barriers to vaccination and potential solutions. METHODS Five community partners in California serving Latinx populations with high social vulnerability participated in the ¡Ándale! ¿Qué Esperas? campaign. Community health workers were hired to deliver outreach (virtual, one-on-one, group based, and information dissemination), vaccinations, and supportive services. We collected data on outreach strategy used (method and location), number of vaccinations provided and reasons for delay, and number of times that supportive services were provided. We used regression models to assess significant predictors of vaccinations and supportive services. RESULTS Community health workers (N = 146) hired from June 1, 2021, through May 31, 2022, performed outreach engagements (n = 6297) and supportive services (n = 313 796), resulting in 130 413 vaccinations and 28 660 vaccine appointments. The number of vaccinations administered was significantly higher at events in which supportive services were provided versus not provided (coefficient = 34.02; 95% CI, 3.34-64.68; P = .03). The odds ratio of supportive services was 3.67 (95% CI, 1.76-7.55) during virtual outreach and 2.95 (95% CI, 2.37-3.69) during one-on-one outreach (P < .001 for both) as compared with information dissemination encounters. Vaccination concerns were reported among 55.0% of vaccinated survey respondents (67.7%, vaccine confidence; 51.7%, access). CONCLUSIONS Supportive services facilitate vaccinations, ease transportation and time barriers, and instill confidence among working-class racial and ethnic minority populations.
Collapse
Affiliation(s)
- Saira Nawaz
- Center for Health Outcomes and Policy Evaluation Studies, College of Public Health, The Ohio State University, Columbus, OH, USA
- Division of Health Services Management and Policy, College of Public Health, The Ohio State University, Columbus, OH, USA
| | - Kyle J Moon
- Center for Health Outcomes and Policy Evaluation Studies, College of Public Health, The Ohio State University, Columbus, OH, USA
- Geisel School of Medicine at Dartmouth College, Hanover, NH, USA
| | - Francis Anagbonu
- Center for Health Outcomes and Policy Evaluation Studies, College of Public Health, The Ohio State University, Columbus, OH, USA
| | - Anne Trinh
- Center for Health Outcomes and Policy Evaluation Studies, College of Public Health, The Ohio State University, Columbus, OH, USA
| | - Lizette Escobedo
- AltaMed Institute for Health Equity, AltaMed Health Services, Los Angeles, CA, USA
| | - Gloria Itzel Montiel
- AltaMed Institute for Health Equity, AltaMed Health Services, Los Angeles, CA, USA
- Claremont Graduate University, Claremont, CA, USA
| |
Collapse
|
34
|
Keane A, Tippett A, Taylor EG, Reese O, Salazar L, De Castro K, Choi C, Ciric C, Taylor M, Mitchell A, Gibson T, Puzniak L, Hubler R, Valluri SR, Wiemken TL, Lopman BA, Kamidani S, Anderson LJ, McLaughlin JM, Rostad CA, Anderson EJ. Effectiveness of BNT162b2 Vaccine for Preventing COVID-19-Related Hospitalizations: A Test-Negative Case-Control Study. Vaccines (Basel) 2024; 12:657. [PMID: 38932386 PMCID: PMC11209557 DOI: 10.3390/vaccines12060657] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2024] [Revised: 06/07/2024] [Accepted: 06/10/2024] [Indexed: 06/28/2024] Open
Abstract
It is important to understand real-world BNT162b2 COVID-19 vaccine effectiveness (VE), especially among racial and ethnic minority groups. We performed a test-negative case-control study to measure BNT162b2 COVID-19 VE in the prevention of COVID-19-associated acute respiratory illness (ARI) hospitalizations at two Atlanta hospitals from May 2021-January 2023 and adjusted for potential confounders by multivariate analysis. Among 5139 eligible adults with ARI, 2763 (53.8%) were enrolled, and 1571 (64.5%) were included in the BNT162b2 analysis. The median age was 58 years (IQR, 44-68), 889 (56.6%) were female, 1034 (65.8%) were African American, 359 (22.9%) were White, 56 (3.6%) were Hispanic ethnicity, 645 (41.1%) were SARS-CoV-2-positive, 412 (26.2%) were vaccinated with a primary series, and 273 (17.4%) had received ≥1 booster of BNT162b2. The overall adjusted VE of the BNT162b2 primary series was 58.5% (95% CI 46.0, 68.1), while the adjusted VE of ≥1 booster was 78.9% (95% CI 70.0, 85.1). The adjusted overall VE of primary series for African American/Black individuals was 64.0% (95% CI 49.9, 74.1) and 82.7% (95% CI 71.9, 89.4) in those who received ≥1 booster. When analysis was limited to the period of Omicron predominance, overall VE of the primary series decreased with widened confidence intervals (24.5%, 95% CI -4.5, 45.4%), while VE of ≥1 booster was maintained at 60.9% (95% CI 42.0, 73.6). BNT162b2 primary series and booster vaccination provided protection against COVID-19-associated ARI hospitalization among a predominantly African American population.
Collapse
Affiliation(s)
- Amy Keane
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA; (A.K.); (A.T.); (E.G.T.); (O.R.); (L.S.); (K.D.C.); (C.C.); (C.C.); (M.T.); (A.M.); (T.G.); (L.J.A.); (E.J.A.)
| | - Ashley Tippett
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA; (A.K.); (A.T.); (E.G.T.); (O.R.); (L.S.); (K.D.C.); (C.C.); (C.C.); (M.T.); (A.M.); (T.G.); (L.J.A.); (E.J.A.)
| | - Elizabeth Grace Taylor
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA; (A.K.); (A.T.); (E.G.T.); (O.R.); (L.S.); (K.D.C.); (C.C.); (C.C.); (M.T.); (A.M.); (T.G.); (L.J.A.); (E.J.A.)
| | - Olivia Reese
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA; (A.K.); (A.T.); (E.G.T.); (O.R.); (L.S.); (K.D.C.); (C.C.); (C.C.); (M.T.); (A.M.); (T.G.); (L.J.A.); (E.J.A.)
| | - Luis Salazar
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA; (A.K.); (A.T.); (E.G.T.); (O.R.); (L.S.); (K.D.C.); (C.C.); (C.C.); (M.T.); (A.M.); (T.G.); (L.J.A.); (E.J.A.)
| | - Khalel De Castro
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA; (A.K.); (A.T.); (E.G.T.); (O.R.); (L.S.); (K.D.C.); (C.C.); (C.C.); (M.T.); (A.M.); (T.G.); (L.J.A.); (E.J.A.)
| | - Chris Choi
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA; (A.K.); (A.T.); (E.G.T.); (O.R.); (L.S.); (K.D.C.); (C.C.); (C.C.); (M.T.); (A.M.); (T.G.); (L.J.A.); (E.J.A.)
| | - Caroline Ciric
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA; (A.K.); (A.T.); (E.G.T.); (O.R.); (L.S.); (K.D.C.); (C.C.); (C.C.); (M.T.); (A.M.); (T.G.); (L.J.A.); (E.J.A.)
| | - Meg Taylor
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA; (A.K.); (A.T.); (E.G.T.); (O.R.); (L.S.); (K.D.C.); (C.C.); (C.C.); (M.T.); (A.M.); (T.G.); (L.J.A.); (E.J.A.)
| | - Anna Mitchell
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA; (A.K.); (A.T.); (E.G.T.); (O.R.); (L.S.); (K.D.C.); (C.C.); (C.C.); (M.T.); (A.M.); (T.G.); (L.J.A.); (E.J.A.)
| | - Theda Gibson
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA; (A.K.); (A.T.); (E.G.T.); (O.R.); (L.S.); (K.D.C.); (C.C.); (C.C.); (M.T.); (A.M.); (T.G.); (L.J.A.); (E.J.A.)
| | - Laura Puzniak
- Pfizer, Inc., New York, NY 10017, USA; (L.P.); (R.H.); (S.R.V.); (T.L.W.); (J.M.M.)
| | - Robin Hubler
- Pfizer, Inc., New York, NY 10017, USA; (L.P.); (R.H.); (S.R.V.); (T.L.W.); (J.M.M.)
| | - Srinivas Rao Valluri
- Pfizer, Inc., New York, NY 10017, USA; (L.P.); (R.H.); (S.R.V.); (T.L.W.); (J.M.M.)
| | - Timothy L. Wiemken
- Pfizer, Inc., New York, NY 10017, USA; (L.P.); (R.H.); (S.R.V.); (T.L.W.); (J.M.M.)
| | - Ben A. Lopman
- Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA;
| | - Satoshi Kamidani
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA; (A.K.); (A.T.); (E.G.T.); (O.R.); (L.S.); (K.D.C.); (C.C.); (C.C.); (M.T.); (A.M.); (T.G.); (L.J.A.); (E.J.A.)
- Center for Childhood Infections and Vaccines, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USA
| | - Larry J. Anderson
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA; (A.K.); (A.T.); (E.G.T.); (O.R.); (L.S.); (K.D.C.); (C.C.); (C.C.); (M.T.); (A.M.); (T.G.); (L.J.A.); (E.J.A.)
- Center for Childhood Infections and Vaccines, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USA
| | - John M. McLaughlin
- Pfizer, Inc., New York, NY 10017, USA; (L.P.); (R.H.); (S.R.V.); (T.L.W.); (J.M.M.)
| | - Christina A. Rostad
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA; (A.K.); (A.T.); (E.G.T.); (O.R.); (L.S.); (K.D.C.); (C.C.); (C.C.); (M.T.); (A.M.); (T.G.); (L.J.A.); (E.J.A.)
- Center for Childhood Infections and Vaccines, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USA
| | - Evan J. Anderson
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA; (A.K.); (A.T.); (E.G.T.); (O.R.); (L.S.); (K.D.C.); (C.C.); (C.C.); (M.T.); (A.M.); (T.G.); (L.J.A.); (E.J.A.)
- Center for Childhood Infections and Vaccines, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USA
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
| |
Collapse
|
35
|
Vázquez E, Juturu P, Burroughs M, McMullin J, Cheney AM. Continuum of Trauma: Fear and Mistrust of Institutions in Communities of Color During the COVID-19 Pandemic. Cult Med Psychiatry 2024; 48:290-309. [PMID: 37776491 PMCID: PMC11217119 DOI: 10.1007/s11013-023-09835-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 08/28/2023] [Indexed: 10/02/2023]
Abstract
Historical, cultural, and social trauma, along with social determinants of health (SDOH), shape health outcomes, attitudes toward medicine, government, and health behaviors among communities of color in the United States (U.S.). This study explores how trauma and fear influence COVID-19 testing and vaccination among Black/African American, Latinx/Indigenous Latin American, and Native American/Indigenous communities. Leveraging community-based participatory research methods, we conducted 11 virtual focus groups from January to March of 2021 with Black/African American (n = 4), Latinx/Indigenous Latin American (n = 4), and Native American/Indigenous (n = 3) identifying community members in Inland Southern California. Our team employed rapid analytic approaches (e.g., template and matrix analysis) to summarize data and identify themes across focus groups and used theories of intersectionality and trauma to meaningfully interpret study findings. Historical, cultural, and social trauma induce fear and mistrust in public health and medical institutions influencing COVID-19 testing and vaccination decisions in communities of color in Inland Southern California. This work showcases the need for culturally and structurally sensitive community-based health interventions that attend to the historical, cultural, and social traumas unique to racial/ethnic minority populations in the U.S. that underlie fear and mistrust of medical, scientific, and governmental institutions.
Collapse
Affiliation(s)
- Evelyn Vázquez
- Department of Social Medicine, Population and Public Health, School of Medicine, University of California, 900 University Avenue, Riverside, CA, 92521-9800, USA
| | - Preeti Juturu
- Department of Community Health Sciences, UCLA Fielding School of Public Health, Los Angeles, CA, USA
| | - Michelle Burroughs
- Center for Healthy Communities, University of California, Riverside, USA
| | - Juliet McMullin
- Department of Family Medicine, School of Medicine, University of California, Irvine, USA
| | - Ann M Cheney
- Department of Social Medicine, Population and Public Health, School of Medicine, University of California, 900 University Avenue, Riverside, CA, 92521-9800, USA.
| |
Collapse
|
36
|
Castellon-Lopez YM, Klomhaus AM, Garcia C, Marquez D, Avila H, Gravette H, Lopez-Chang R, Ortega B, Norris KC, Brown AF, Blanco L. MivacunaLA (MyshotLA): A Community-Partnered Mobile Phone Intervention to Improve COVID-19 Vaccination Behaviors among Low-Income, Spanish-Speaking, and Immigrant Latino Parents or Caregivers. Vaccines (Basel) 2024; 12:511. [PMID: 38793762 PMCID: PMC11125729 DOI: 10.3390/vaccines12050511] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2024] [Revised: 05/02/2024] [Accepted: 05/04/2024] [Indexed: 05/26/2024] Open
Abstract
We developed and tested MivacunaLA/MyshotLA, a community-informed mobile phone intervention, to increase COVID-19 vaccination among Latino parents/caretakers of minors in under-resourced areas of Los Angeles by addressing misinformation and building trust. We recruited Latino parents/caregivers with at least one unvaccinated child in East and South Los Angeles in the summer of 2021 and evaluated MivacunaLA as a randomized controlled trial with a wait-list control group. A difference-in-difference analysis showed Latino parents/caregivers that participated in MivacunaLA (n = 246), in comparison to the control group, were 15 percentage points more likely (p = 0.04) to report vaccination of minors aged 12-17 years, and 12 percentage points more likely (p = 0.03) to report a positive intention to vaccinate minors aged 2-11 years (when COVID-19 vaccines became available). Mobile phone-delivered digital interventions using videos and culturally tailored educational material to promote COVID-19 vaccine confidence can be an effective way to combat misinformation and deliver timely information to marginalized communities. Community-based participatory research approaches are crucial to advance health equity among minority communities, especially immigrant Spanish-speaking underserved communities.
Collapse
Affiliation(s)
- Yelba M. Castellon-Lopez
- Department of Biomedical Sciences, Cedars-Sinai Medical Center, Cancer Research Center for Health Equity, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA 90048, USA;
| | - Alexandra M. Klomhaus
- Department of Medicine Statistics Core, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA;
| | - Cruz Garcia
- School of Public Policy, Pepperdine University, Malibu, CA 90263, USA; (C.G.); (L.B.)
| | - Denise Marquez
- Department of Biomedical Sciences, Cedars-Sinai Medical Center, Cancer Research Center for Health Equity, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA 90048, USA;
| | - Hilda Avila
- Families in Schools, Los Angeles, CA 90017, USA;
| | | | | | | | - Keith C. Norris
- Division of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; (K.C.N.); (A.F.B.)
| | - Arleen F. Brown
- Division of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; (K.C.N.); (A.F.B.)
- Olive View-UCLA Medical Center, Sylmar, CA 91342, USA
| | - Luisa Blanco
- School of Public Policy, Pepperdine University, Malibu, CA 90263, USA; (C.G.); (L.B.)
| |
Collapse
|
37
|
Burrage RL, Mills KJ, Coyaso HC, Gronowski CK, Godinet MT. Community Resilience and Cultural Responses in Crisis: Lessons Learned from Pacific Islander Responses to the COVID-19 Pandemic in the USA. J Racial Ethn Health Disparities 2024; 11:560-573. [PMID: 36849862 PMCID: PMC9970122 DOI: 10.1007/s40615-023-01541-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2022] [Revised: 02/13/2023] [Accepted: 02/14/2023] [Indexed: 03/01/2023]
Abstract
Pacific Islander communities in the USA experienced some of the most severe effects of the COVID-19 pandemic. This qualitative synthesis examines the literature on Pacific Islander community responses and lessons learned from COVID-19, using a systematic search that identified 28 articles with this focus. Thematic analysis was subsequently used to classify both documented efforts by Pacific Islander communities to respond to the pandemic, as well as lessons learned and best practices from research in this area. Results revealed multiple efforts to address the pandemic, including Pacific Islander grassroots approaches, government responses, inter-sector collaboration, and research. Results further emphasized the importance of culturally and linguistically responsive outreach and messaging; partnership, engagement, and capacity building; and changes in research and policy approaches to promote health equity. Future efforts to address public health crises should make the most of Pacific Islander cultural approaches to disaster response. To achieve this, government and other organizations that work with PI communities need to support the development of the PI leadership, healthcare and research workforces, and work with Pacific Islander communities to build long-term, sustainable, and trustworthy partnerships.
Collapse
Affiliation(s)
- Rachel L Burrage
- Department of Social Work, Thompson School of Social Work & Public Health, University of Hawai'i at Mānoa, Honolulu, USA.
| | - Kelsey J Mills
- Department of Social Work, Thompson School of Social Work & Public Health, University of Hawai'i at Mānoa, Honolulu, USA
| | - Hope C Coyaso
- Department of Social Work, Thompson School of Social Work & Public Health, University of Hawai'i at Mānoa, Honolulu, USA
| | - Chrisovolandou K Gronowski
- Department of Social Work, Thompson School of Social Work & Public Health, University of Hawai'i at Mānoa, Honolulu, USA
| | - Meripa T Godinet
- Department of Social Work, Thompson School of Social Work & Public Health, University of Hawai'i at Mānoa, Honolulu, USA
| |
Collapse
|
38
|
Mensah GA, Johnson LE, Zhang X, Stinson N, Carrington K, Malla G, Land SR, Huff E, Freeman N, Stoney C, Ampey B, Paltoo D, Clark D, Rajapakse N, Ilias MR, Haase KP, Punturieri A, Kurilla MG, Archer H, Bolek M, Santos M, Wilson-Frederick S, Devaney S, Marshall V, Farhat T, Hooper MW, Wilson DR, Perez-Stable EJ, Gibbons GH. Community Engagement Alliance (CEAL): A National Institutes of Health Program to Advance Health Equity. Am J Public Health 2024; 114:S12-S17. [PMID: 37944098 PMCID: PMC10785165 DOI: 10.2105/ajph.2023.307476] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/26/2023] [Indexed: 11/12/2023]
Affiliation(s)
- George A Mensah
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Lenora E Johnson
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Xinzhi Zhang
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Nathan Stinson
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Kelli Carrington
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Gargya Malla
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Stephanie R Land
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Erynn Huff
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Naomi Freeman
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Catherine Stoney
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Bryan Ampey
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Dina Paltoo
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Dave Clark
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Nishadi Rajapakse
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Maliha R Ilias
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Karen Plevock Haase
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Antonello Punturieri
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Michael G Kurilla
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Hillary Archer
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Michelle Bolek
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Melanie Santos
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Shondelle Wilson-Frederick
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Stephanie Devaney
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Vanessa Marshall
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Tilda Farhat
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Monica Webb Hooper
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - David R Wilson
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Eliseo J Perez-Stable
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| | - Gary H Gibbons
- George A. Mensah, Xinzhi Zhang, Maliha R. Ilias, and Karen Plevock Haase are with the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Lenora E. Johnson, Hillary Archer, Michelle Bolek, Melanie Santos, and Shondelle Wilson-Frederick are with the Office of Science Policy, Engagement, Education, and Communications, NHLBI. Nathan Stinson Jr, Kelli Carrington, Gargya Malla, Vanessa Marshall, Tilda Farhat, Monica Webb Hooper, and Eliseo J. Perez-Stable are with the National Institute on Minority Health and Health Disparities, NIH. Stephanie R. Land is with the National Cancer Institute, NIH. Erynn Huff and Naomi Freeman are with the Office of Management, Immediate Office of the Director, NHLBI. Catherine Stoney is with Stoney Consulting, Washington, DC. Bryan Ampey and Dina Paltoo are with the Immediate Office of the Director, NHLBI. Dave Clark is with the Eunice Kennedy Schriver National Institute of Child Health and Human Development, NIH. Nishadi Rajapakse is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Antonello Punturieri is with the Division of Lung Diseases, NHLBI. Michael G. Kurilla is with the National Center for Advancing Translational Sciences, NIH. Stephanie Devaney is with the All of Us Research Program, Office of the Director, NIH. David R. Wilson is with the Office of the Director, NIH
| |
Collapse
|
39
|
Al-Saudi G, Thabit AK, Jose J, Badr AF, Jad L, Kaae S, Jacobsen R. Exploring the reasons behind low COVID-19 vaccination coverage in ethnic minorities-A qualitative study among Arabic-speaking public in Denmark. Health Policy 2024; 139:104965. [PMID: 38104373 DOI: 10.1016/j.healthpol.2023.104965] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2023] [Revised: 12/06/2023] [Accepted: 12/11/2023] [Indexed: 12/19/2023]
Abstract
AIMS In Denmark, COVID-19 infection rates have been higher, and vaccination coverage has been lower in areas with many residents from ethnic minority backgrounds. This study aimed to explore COVID-19 vaccination perceptions among Arabic-speaking minorities in Denmark. MATERIALS AND METHODS A total of 16 individuals, varying in age, gender, education, employment, health, vaccination status, and the Arabic-speaking country of origin, were recruited and interviewed in Arabic. The interviews were transcribed verbatim, translated into English, and analyzed using directed thematic analysis. RESULTS Most interviewees had some knowledge about how vaccines work to prevent infections; however, a wide spectrum of opinions about the effectiveness and safety of COVID-19 vaccines and vaccination policies in Denmark emerged. COVID-19 vaccination issues were extensively discussed in Arabic-speaking communities, but consensus was rarely reached. Many participants felt confused and only took vaccines for practical considerations, such as travel. Due to language barriers, some participants experienced difficulties in understanding vaccination-related information in electronic invitations from the health authorities and at vaccination centers, with family members often stepping in to provide translations. CONCLUSIONS Systematic efforts to actively disseminate translated COVID-19 vaccination information are needed to support ethnic minority individuals in making informed decisions.
Collapse
Affiliation(s)
- Ghuna Al-Saudi
- Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Abrar K Thabit
- Pharmacy Practice Department, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Jimmy Jose
- School of Pharmacy, University of Nizwa, Nizwa, Sultanate of Oman
| | - Aisha F Badr
- Pharmacy Practice Department, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Lama Jad
- Pharmacy Practice Department, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Susanne Kaae
- Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Ramune Jacobsen
- Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
| |
Collapse
|
40
|
Eichelberger L, Hansen A, Cochran P, Hahn M, Fried R. COVID-19 vaccine decision-making in remote Alaska between November 2020 and November 2021. Int J Circumpolar Health 2023; 82:2242582. [PMID: 37535846 PMCID: PMC10402834 DOI: 10.1080/22423982.2023.2242582] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2022] [Revised: 07/17/2023] [Accepted: 07/26/2023] [Indexed: 08/05/2023] Open
Abstract
Vaccine hesitancy is an ongoing barrier to achieve sufficient COVID-19 vaccination coverage. Although there are many studies globally of vaccine hesitancy based on large survey samples, there are fewer in-depth qualitative studies that explore vaccine hesitancy and acceptance as a spectrum of decision-making. In this paper, we begin to describe vaccination decision-making among 58 adults living in remote Alaska based on three waves of online surveys and follow-up semi-structured interviews conducted between November 2020 and November 2021. The survey question of intention was not a predictor of adoption for about one third of the interviewees who were unvaccinated when they took the survey (n=12, 35%). Over half of all interviewees (n=37, 64%) had vaccine-related concerns, including 25 vaccinated individuals (representing 57% of vaccinated interviewees). Most interviewees reported that they learned about COVID-19 vaccines through interpersonal interactions (n=30, 52%) and/or a variety of media sources (n=29, 50%). The major facilitators of acceptance were trust in the information source (n=20, 48% of the 42 who responded), and learning from the experiences of family, friends, and the broader community (n=12, 29%). Further, trust and having a sense of agency appears to be important to interviewee decision-making, regardless of vaccination status and intention.
Collapse
Affiliation(s)
- Laura Eichelberger
- Tribal Water Center, Research Services, Alaska Native Tribal Health Consortium, Anchorage, AK, USA
| | - Amanda Hansen
- Tribal Water Center, Research Services, Alaska Native Tribal Health Consortium, Anchorage, AK, USA
| | | | - Micah Hahn
- Institute for Circumpolar Health Studies, University of Alaska Anchorage, Anchorage, AK, USA
| | - Ruby Fried
- Institute for Circumpolar Health Studies, University of Alaska Anchorage, Anchorage, AK, USA
| |
Collapse
|
41
|
Ezeh N, Sirek G, Ulysse SN, Williams JN, Chandler MT, Ojikutu BO, York M, Crespo-Bosque M, Jean-Jacques M, Roberson T, Mancera-Cuevas K, Milaeger H, Losina E, Dhand A, Son MB, Ramsey-Goldman R, Feldman CH. Understanding Stakeholders' Perspectives to Increase COVID-19 Vaccine and Booster Uptake Among Black Individuals With Rheumatic Conditions. Arthritis Care Res (Hoboken) 2023; 75:2508-2518. [PMID: 37309724 PMCID: PMC10716359 DOI: 10.1002/acr.25172] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2023] [Revised: 05/09/2023] [Accepted: 06/08/2023] [Indexed: 06/14/2023]
Abstract
OBJECTIVE Disparities in COVID-19 vaccine and booster uptake persist. This study aimed to obtain perspectives from community and physician stakeholders on COVID-19 vaccine and booster hesitancy and strategies to promote vaccine uptake among Black individuals with rheumatic and musculoskeletal conditions. METHODS We invited community leaders and physicians in greater Boston and Chicago to participate in semi-structured interviews using a moderator guide developed a priori. Participants were queried about how to best address vaccine hesitancy, strategies to target high-risk populations, and factors to identify future community leaders. Interviews were audio recorded, transcribed verbatim, and analyzed thematically using Dedoose. RESULTS A total of 8 physicians and 12 community leaders participated in this study between November 2021 and October 2022. Qualitative analyses revealed misinformation/mixed messaging and mistrust, with subthemes including conspiracy theories, concerns regarding vaccine development and function, racism and historical injustices, and general mistrust of health care systems as the top cited reasons for COVID-19 vaccine hesitancy. Participants also shared demographic-specific differences, such as race, ethnicity, age, and gender that influenced the identified themes, with emphasis on COVID-19 vaccine access and apathy. Strategies for community-based vaccine-related information dissemination included personal storytelling with an iterative and empathetic approach, while recognizing the importance of protecting community leader well-being. CONCLUSION To increase vaccine uptake among Black individuals with rheumatic conditions, strategies should acknowledge and respond to racial/ethnic and socioeconomic injustices that engender vaccine hesitancy. Messaging should be compassionate, individually tailored, and recognize heterogeneity in experiences and opinions. Results from these analyses will inform a planned community-based intervention in Boston and Chicago.
Collapse
Affiliation(s)
- Nnenna Ezeh
- Department of Dermatology, Brigham and Women’s Hospital, Boston, MA
- Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
| | - Greta Sirek
- Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
| | - Sciaska N. Ulysse
- Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
| | - Jessica N. Williams
- Division of Rheumatology, Department of Medicine, Emory School of Medicine, Atlanta, GA
| | - Mia T. Chandler
- The Rheumatology Program, Boston Children’s Hospital, Boston, MA
- Harvard Medical School, Boston, MA
| | - Bisola O. Ojikutu
- Harvard Medical School, Boston, MA
- Boston Public Health Commission, Boston, MA
- Division of Global Health Equity, Brigham and Women’s Hospital, Boston, MA
| | - Michael York
- Department of Rheumatology, Boston Medical Center, Boston, MA
| | | | | | - Tonya Roberson
- College of Health and Human Services, Governors State University, University Park, IL
| | | | - Holly Milaeger
- Division of Rheumatology, Department of Medicine Northwestern Medicine/Feinberg School of Medicine, Chicago, IL
| | - Elena Losina
- Harvard Medical School, Boston, MA
- The Orthopedic and Arthritis Center for Outcomes Research, Department of Orthopedics, Brigham and Women’s Hospital, Boston, MA
| | - Amar Dhand
- Division of Neurology, Brigham and Women’s Hospital, Boston, MA
| | - Mary Beth Son
- The Rheumatology Program, Boston Children’s Hospital, Boston, MA
- Harvard Medical School, Boston, MA
| | - Rosalind Ramsey-Goldman
- Division of Rheumatology, Department of Medicine Northwestern Medicine/Feinberg School of Medicine, Chicago, IL
| | - Candace H. Feldman
- Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
- Harvard Medical School, Boston, MA
| |
Collapse
|
42
|
Goodwill JR, Fike KJ. Black in the pandemic: Comparing experiences of mistrust, anxiety, and the COVID-19 vaccine among Black adults in the U.S. Soc Sci Med 2023; 338:116302. [PMID: 37871396 DOI: 10.1016/j.socscimed.2023.116302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2023] [Revised: 08/21/2023] [Accepted: 10/04/2023] [Indexed: 10/25/2023]
Abstract
COVID-19 vaccine decisions are shaped by many factors including historical and contemporary patterns of medical mistreatment of marginalized communities. In attending to these concerns, we measured whether fear of COVID-19, general feelings of mistrust, and race-specific mistrust of the government and healthcare providers are indirectly associated with COVID-19 vaccination status via anxiety among Black Americans. We analyzed responses from 996 Black adults who participated in the AmeriSpeak panel - a nationally representative probability-based sample recruited from the National Opinion Research Center from April-June 2022. We used multiple-group structural equation modeling to compare outcomes among those who lost a loved one to COVID-19 to those who did not. Results indicate that fear of COVID-19 was associated with a greater probability of being fully vaccinated for those who lost a family member/friend. Race-specific mistrust was positively associated with anxiety, but was negatively associated with being fully vaccinated for bereaved Black Americans. Targeted efforts are needed to specifically reach those who lost a loved one to COVID-19. More within-group evaluations are needed to identify barriers to COVID-19 vaccination that are specific to Black Americans living with loss and grief.
Collapse
Affiliation(s)
- Janelle R Goodwill
- University of Chicago, Crown Family School of Social Work, Policy, and Practice, United States.
| | - Kayla J Fike
- Vanderbilt University, Peabody College of Education and Human Development, United States
| |
Collapse
|
43
|
Jiao L, Wachinger J, Dasch S, Bärnighausen T, McMahon SA, Chen S. Calculation, knowledge, and identity: Dimensions of trust when making COVID-19 vaccination choices in China. SSM. QUALITATIVE RESEARCH IN HEALTH 2023; 4:100288. [PMID: 37334196 PMCID: PMC10232919 DOI: 10.1016/j.ssmqr.2023.100288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/03/2023] [Revised: 05/21/2023] [Accepted: 05/22/2023] [Indexed: 06/20/2023]
Abstract
Vaccine hesitancy threatens the response to the COVID-19 pandemic and to other infectious disease outbreaks globally. Fostering trust has been highlighted as a critical factor in addressing vaccine hesitancy and expanding vaccine coverage, but qualitative exploration of trust in the context of vaccination remains limited. We contribute to filling this gap by providing a comprehensive qualitative analysis of trust in the context of COVID-19 vaccination in China. We conducted 40 in-depth interviews with Chinese adults in December 2020. During data collection, trust emerged as a highly salient topic. Interviews were audio-recorded, transcribed verbatim, translated into English, and analyzed with a combination of inductive and deductive coding. Following established trust literature, we differentiate between three types of trust - calculation-based trust, knowledge-based trust, and identity-based trust - which we grouped across components of the health system, as informed by the WHO's building blocks. Our results highlight how participants attributed their level of trust in COVID-19 vaccines to their trust in the medical technology itself (based on assessing risks and benefits or previous vaccination experiences), the service delivery and health workforce (informed by past experiences with health providers and their role throughout the pandemic), and leadership and governance (drawing on notions of government performance and patriotism). Reducing negative impact from past vaccine controversies, increasing the credibility of pharmaceutical companies, and fostering clear communication are identified as important channels for facilitating trust. Our findings emphasize a strong need for comprehensive information on COVID-19 vaccines and increased promotion of vaccination by credible figures.
Collapse
Affiliation(s)
- Lirui Jiao
- Columbia University Mailman School of Public Health, New York, USA
| | - Jonas Wachinger
- Heidelberg Institute of Global Health, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - Selina Dasch
- Heidelberg Institute of Global Health, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - Till Bärnighausen
- Heidelberg Institute of Global Health, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
- Department of Global Health and Population, Harvard School of Public Health, Massachusetts, USA
- Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
| | - Shannon A McMahon
- Heidelberg Institute of Global Health, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
- International Health Department, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA
| | - Simiao Chen
- Heidelberg Institute of Global Health, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
- Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
| |
Collapse
|
44
|
Bacong AM, Haro-Ramos AY. Willingness to Receive the COVID-19 Vaccine in California: Disparities by Race and Citizenship Status. J Racial Ethn Health Disparities 2023; 10:2911-2920. [PMID: 36449129 PMCID: PMC9713137 DOI: 10.1007/s40615-022-01468-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2022] [Revised: 11/18/2022] [Accepted: 11/21/2022] [Indexed: 12/05/2022]
Abstract
Although it is widely acknowledged that racialized minorities may report lower COVID-19 vaccine willingness compared to non-Hispanic white individuals, what is less known, however, is whether the willingness to receive the COVID-19 vaccine also differs by citizenship. Understanding disparities in vaccine willingness by citizenship is particularly important given the misleading rhetoric of some political leaders regarding vaccine eligibility by citizenship status. This study used the 2020 California Health Interview Survey (n = 21,949) to examine disparities in vaccine willingness by race/ethnicity and citizenship among Asian, Latinx, and non-Hispanic white individuals. Overall, 77.7% of Californians indicated that they were willing to receive the COVID-19 vaccine if it was made available. However, there were distinct differences by race/ethnicity and citizenship. Asian people, regardless of citizenship, had the highest predicted probability of vaccine willingness, accounting for demographic, socioeconomic, and health factors. Non-citizen Latinx and non-citizen non-Hispanic white people had higher predicted probabilities of vaccine willingness compared to their US-born counterparts, accounting for demographic, socioeconomic, and health factors. Our results reveal that although vaccine willingness may be high among non-citizen individuals, it may not necessarily translate into actual vaccine uptake. Furthermore, while individual-level factors may account for some of the differences in vaccine willingness by race/ethnicity and citizenship, other institutional and structural barriers prevent vaccine uptake.
Collapse
Affiliation(s)
- Adrian Matias Bacong
- Stanford University Center for Asian Health Research and Education, Stanford, CA, USA.
- Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
| | - Alein Y Haro-Ramos
- School of Public Health, University of California Berkeley, Berkeley, CA, USA
| |
Collapse
|
45
|
Rossi MM, Parisi MA, Cartmell KB, McFall D. Understanding COVID-19 vaccine hesitancy in the Hispanic adult population of South Carolina: a complex mixed-method design evaluation study. BMC Public Health 2023; 23:2359. [PMID: 38017470 PMCID: PMC10685550 DOI: 10.1186/s12889-023-16771-9] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2022] [Accepted: 09/16/2023] [Indexed: 11/30/2023] Open
Abstract
BACKGROUND In August 2021, only 47.6% of all eligible residents in South Carolina (SC) had received at least one dose of the COVID-19 vaccine, with only 41% having completed their vaccination series. Additionally, only 27% of all Hispanics in SC had completed their vaccination series compared to 34.1% of non-Hispanics. Vaccine hesitancy is a complex phenomenon that is context and vaccine-specific. Focusing on unvaccinated Hispanics living in rural areas of SC, this study aimed to identify barriers to vaccination and provide an educational intervention designed to address vaccine hesitancy. METHODS A complex mixed-methods evaluation design was used to conduct this study. First, in-person vaccine educational sessions were implemented, along with a pre-post-test survey, to assess changes in knowledge, attitudes, motivations, barriers, and intentions to receive COVID-19 vaccination. Second, in-person follow-up focus groups were held with the same participants to gather in-depth insight about participants' knowledge and attitudes about the COVID-19 vaccination. Third, an online follow-up survey was conducted to assess the effect of the training and discussion session on COVID-19 vaccination. Study outcomes were assessed among the 17 individuals who participated in the educational sessions and focus group discussions. RESULTS Findings revealed that for unvaccinated Hispanics living in South Carolina; vaccine hesitancy was primarily driven by: 1) misinformation and information coming from unverified sources and 2) negative perceptions of the safety and effectiveness of the COVID-19 vaccines. Specifically, participants were fearful that the vaccine development was rushed and that the vaccines might contain questionable ingredients that could cause strong side effects or even death. Participants were also concerned that vaccination might cause them to get sick and be hospitalized, which would have financial implications since they could not afford healthcare or take time off work. CONCLUSIONS Program implementation and mass communication campaigns should focus on COVID-19 vaccine safety and effectiveness, including side effects, what to expect after being vaccinated, and how to look for information from reputable sources. The educational session implemented proved to be effective and helped reduce vaccine hesitancy since most participants (80%) self-reported receiving a COVID-19 vaccine after program participation.
Collapse
Affiliation(s)
- Maria Mercedes Rossi
- Department of Food, Nutrition, and Packaging Sciences, C228 Pool Agricultural Center, Clemson University, Clemson, SC, 29631, USA.
| | - Michelle A Parisi
- Department Nutritional Sciences, University of Georgia, 206 Hoke Smith Annex, Athens, GA, 30602, USA
| | - Kathleen B Cartmell
- Department of Public Health Sciences, Clemson University, 534 Edwards Hall, Clemson, SC, 29634, USA
| | - Danielle McFall
- Rural Health and Nutrition Program Team, Clemson University, 120 Lehotsky Hall, Clemson, SC, 29634, USA
| |
Collapse
|
46
|
Baghani M, Fathalizade F, Loghman AH, Samieefar N, Ghobadinezhad F, Rashedi R, Baghsheikhi H, Sodeifian F, Rahimzadegan M, Akhlaghdoust M. COVID-19 vaccine hesitancy worldwide and its associated factors: a systematic review and meta-analysis. SCIENCE IN ONE HEALTH 2023; 2:100048. [PMID: 39077035 PMCID: PMC11262288 DOI: 10.1016/j.soh.2023.100048] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Accepted: 10/26/2023] [Indexed: 07/31/2024]
Abstract
Introduction The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has taken a toll on humans, and the development of effective vaccines has been a promising tool to end the pandemic. However, for a vaccination program to be successful, a considerable proportion of the community must be vaccinated. Hence, public acceptance of coronavirus disease 2019 (COVID-19) vaccines has become the key to controlling the pandemic. Recent studies have shown vaccine hesitancy increasing over time. This systematic review aims to evaluate the COVID-19 vaccine hesitancy rate and related factors in different communities. Method A comprehensive search was performed in MEDLINE (via PubMed), Scopus, and Web of Science from January 1, 2019 to January 31, 2022. All relevant descriptive and observational studies (cross-sectional and longitudinal) on vaccine hesitancy and acceptance were included in this systematic review. In the meta-analysis, odds ratio (OR) was used to assess the effects of population characteristics on vaccine hesitancy, and event rate (acceptance rate) was the effect measure for overall acceptance. Publication bias was assessed using the funnel plot, Egger's test, and trim-and-fill methods. Result A total of 135 out of 6,417 studies were included after screening. A meta-analysis of 114 studies, including 849,911 participants, showed an overall acceptance rate of 63.1%. In addition, men, married individuals, educated people, those with a history of flu vaccination, those with higher income levels, those with comorbidities, and people living in urban areas were less hesitant. Conclusion Increasing public awareness of the importance of COVID-19 vaccines in overcoming the pandemic is crucial. Being men, living in an urban region, being married or educated, having a history of influenza vaccination, having a higher level of income status, and having a history of comorbidities are associated with higher COVID-19 vaccine acceptance.
Collapse
Affiliation(s)
- Matin Baghani
- Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Cognitive and Neuroscience Research Center (CNRC), Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
| | - Farzan Fathalizade
- Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Cognitive and Neuroscience Research Center (CNRC), Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
| | - Amir Hossein Loghman
- USERN Office, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Network of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran
| | - Noosha Samieefar
- USERN Office, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Network of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran
| | - Farbod Ghobadinezhad
- Student Research Committee, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
- USERN Office, Kermanshah University of Medical Sciences, Kermanshah, Iran
- Network of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran
| | - Ronak Rashedi
- USERN Office, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Network of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran
| | - Hediyeh Baghsheikhi
- USERN Office, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Network of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran
| | - Fatemeh Sodeifian
- USERN Office, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- USERN Office, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Milad Rahimzadegan
- Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- USERN Office, Functional Neurosurgery Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Meisam Akhlaghdoust
- Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- USERN Office, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- USERN Office, Functional Neurosurgery Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Network of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran
| |
Collapse
|
47
|
Guay M, Maquiling A, Chen R, Lavergne V, Baysac DJ, Dubé È, MacDonald SE, Driedger SM, Gilbert NL. Racial disparities in COVID-19 vaccination in Canada: results from the cross-sectional Canadian Community Health Survey. CMAJ Open 2023; 11:E1075-E1082. [PMID: 37989513 PMCID: PMC10681669 DOI: 10.9778/cmajo.20230026] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2023] Open
Abstract
BACKGROUND Racial and ethnic disparities in COVID-19 vaccination coverage have been observed in Canada and in other countries. We aimed to compare vaccination coverage for at least 1 dose of a COVID-19 vaccine between First Nations people living off reserve and Métis, Black, Arab, Chinese, South Asian and White people. METHODS We used data collected between June 2021 and June 2022 by Statistics Canada's Canadian Community Health Survey, a large, nationally representative cross-sectional study. The analysis included 64 722 participants aged 18 years or older from the 10 provinces. We used a multiple logistic regression model to determine associations between vaccination status and race, controlling for collection period, region of residence, age, gender and education. RESULTS Nonvaccination against COVID-19 was more frequent in off-reserve First Nations people (adjusted odds ratio [OR] 1.8, 95% confidence interval [CI] 1.2-2.7) and Black people (adjusted OR 1.7, 95% CI 1.1-2.6), and less frequent among South Asian people (adjusted OR 0.3, 95% CI 0.1-0.7) compared to White people. INTERPRETATION This analysis showed significant inequalities in COVID-19 vaccine uptake between racial/ethnic populations in Canada. Further research is needed to understand the sociocultural, structural and systemic facilitators of and barriers to vaccination across racial groups, and to identify strategies that may improve vaccination uptake among First Nations and Black people.
Collapse
Affiliation(s)
- Mireille Guay
- Public Health Agency of Canada (Guay, Maquiling, Chen, Lavergne, Baysac, Gilbert), Ottawa, Ont.; Institut national de santé publique du Québec (Dubé); Département d'anthropologie (Dubé), Université Laval, Québec, Que.; Faculty of Nursing (MacDonald) and School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Department of Community Health Sciences (Driedger), Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; École de santé publique (Gilbert), Université de Montréal, Montréal, Que.
| | - Aubrey Maquiling
- Public Health Agency of Canada (Guay, Maquiling, Chen, Lavergne, Baysac, Gilbert), Ottawa, Ont.; Institut national de santé publique du Québec (Dubé); Département d'anthropologie (Dubé), Université Laval, Québec, Que.; Faculty of Nursing (MacDonald) and School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Department of Community Health Sciences (Driedger), Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; École de santé publique (Gilbert), Université de Montréal, Montréal, Que
| | - Ruoke Chen
- Public Health Agency of Canada (Guay, Maquiling, Chen, Lavergne, Baysac, Gilbert), Ottawa, Ont.; Institut national de santé publique du Québec (Dubé); Département d'anthropologie (Dubé), Université Laval, Québec, Que.; Faculty of Nursing (MacDonald) and School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Department of Community Health Sciences (Driedger), Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; École de santé publique (Gilbert), Université de Montréal, Montréal, Que
| | - Valérie Lavergne
- Public Health Agency of Canada (Guay, Maquiling, Chen, Lavergne, Baysac, Gilbert), Ottawa, Ont.; Institut national de santé publique du Québec (Dubé); Département d'anthropologie (Dubé), Université Laval, Québec, Que.; Faculty of Nursing (MacDonald) and School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Department of Community Health Sciences (Driedger), Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; École de santé publique (Gilbert), Université de Montréal, Montréal, Que
| | - Donalyne-Joy Baysac
- Public Health Agency of Canada (Guay, Maquiling, Chen, Lavergne, Baysac, Gilbert), Ottawa, Ont.; Institut national de santé publique du Québec (Dubé); Département d'anthropologie (Dubé), Université Laval, Québec, Que.; Faculty of Nursing (MacDonald) and School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Department of Community Health Sciences (Driedger), Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; École de santé publique (Gilbert), Université de Montréal, Montréal, Que
| | - Ève Dubé
- Public Health Agency of Canada (Guay, Maquiling, Chen, Lavergne, Baysac, Gilbert), Ottawa, Ont.; Institut national de santé publique du Québec (Dubé); Département d'anthropologie (Dubé), Université Laval, Québec, Que.; Faculty of Nursing (MacDonald) and School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Department of Community Health Sciences (Driedger), Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; École de santé publique (Gilbert), Université de Montréal, Montréal, Que
| | - Shannon E MacDonald
- Public Health Agency of Canada (Guay, Maquiling, Chen, Lavergne, Baysac, Gilbert), Ottawa, Ont.; Institut national de santé publique du Québec (Dubé); Département d'anthropologie (Dubé), Université Laval, Québec, Que.; Faculty of Nursing (MacDonald) and School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Department of Community Health Sciences (Driedger), Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; École de santé publique (Gilbert), Université de Montréal, Montréal, Que
| | - S Michelle Driedger
- Public Health Agency of Canada (Guay, Maquiling, Chen, Lavergne, Baysac, Gilbert), Ottawa, Ont.; Institut national de santé publique du Québec (Dubé); Département d'anthropologie (Dubé), Université Laval, Québec, Que.; Faculty of Nursing (MacDonald) and School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Department of Community Health Sciences (Driedger), Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; École de santé publique (Gilbert), Université de Montréal, Montréal, Que
| | - Nicolas L Gilbert
- Public Health Agency of Canada (Guay, Maquiling, Chen, Lavergne, Baysac, Gilbert), Ottawa, Ont.; Institut national de santé publique du Québec (Dubé); Département d'anthropologie (Dubé), Université Laval, Québec, Que.; Faculty of Nursing (MacDonald) and School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Department of Community Health Sciences (Driedger), Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; École de santé publique (Gilbert), Université de Montréal, Montréal, Que
| |
Collapse
|
48
|
Eichelberger L, Hansen A, Cochran P, Fried R, Hahn M. "In the beginning, I said I wouldn't get it.": Hesitant adoption of the COVID-19 vaccine in remote Alaska between November 2020 and 2021. Soc Sci Med 2023; 334:116197. [PMID: 37666096 DOI: 10.1016/j.socscimed.2023.116197] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2023] [Revised: 08/07/2023] [Accepted: 08/29/2023] [Indexed: 09/06/2023]
Abstract
Achieving sufficient COVID-19 vaccination coverage has been hindered in many areas by vaccine hesitancy. Many studies based on large survey samples have characterized vaccine refusal, but there are fewer in-depth qualitative studies that explore hesitant adoption: the middle-ground between vaccine acceptance and refusal, and how individuals may move across this continuum depending on their lived experience. For this paper, we use the narratives of 25 adults living in off-road, predominately Alaska Native communities to describe the complex decision-making processes undertaken by 'hesitant adopters', defined in our study as those who completed their initial COVID-19 series despite reporting hesitancy. Interviewees' stories help illustrate how hesitant adopters' decision-making processes involved making sense of information through interactions with trusted individuals, lived experiences, observations, emotions, and personal motivations. For the majority of these hesitant adopters' (n = 20, 80%) interpersonal interactions were key in helping to make the decision to get vaccinated. Over half of the interviewees (n = 14, 56%) described how conversations with individuals they trusted, including healthcare providers, family, friends, and interactions through their professional network made them feel safe. One third of the hesitant adopters (n = 7, 28%) attributed their decision to get vaccinated based on the influence of Alaska Native Elders including their knowledge, personal experiences, as well as being motivated by the desire to protect them. Independent research was also important to about a quarter of hesitant adopters (n = 6, 24%), and for these interviewees it was the process of gathering information on their own and learning from others, especially healthcare providers who could answer their questions and alleviate their concerns. This paper illustrates the temporality of vaccine decision-making: vaccine acceptance for those who are hesitant may be an ongoing process that is influenced by personal experience, relationships, and context.
Collapse
Affiliation(s)
- Laura Eichelberger
- Alaska Native Tribal Health Consortium, Tribal Water Center. 4000 Ambassador Drive Anchorage, Alaska, 99508, USA.
| | - Amanda Hansen
- Alaska Native Tribal Health Consortium, Tribal Water Center. 4000 Ambassador Drive Anchorage, Alaska, 99508, USA.
| | - Patricia Cochran
- Alaska Native Science Commission. 429 L Street, Anchorage, AK 99501, USA.
| | - Ruby Fried
- University of Alaska Anchorage (UAA), Institute for Circumpolar Health Studies (ICHS), 1901 Bragaw, Suite 220, Anchorage, Alaska, 99508, USA.
| | - Micah Hahn
- University of Alaska Anchorage (UAA), Institute for Circumpolar Health Studies (ICHS), 1901 Bragaw, Suite 220, Anchorage, Alaska, 99508, USA.
| |
Collapse
|
49
|
Winters M, Christie S, Lepage C, Malik AA, Bokemper S, Abeyesekera S, Boye B, Moini M, Jamil Z, Tariq T, Beresh T, Kazymyrova G, Palamar L, Paintsil E, Faller A, Seusan A, Bonnevie E, Smyser J, Khan K, Gulaid M, Francis S, Warren JL, Thomson A, Omer SB. Persuasive COVID-19 vaccination campaigns on Facebook and nationwide vaccination coverage in Ukraine, India, and Pakistan. PLOS GLOBAL PUBLIC HEALTH 2023; 3:e0002357. [PMID: 37756298 PMCID: PMC10529538 DOI: 10.1371/journal.pgph.0002357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/20/2023] [Accepted: 08/11/2023] [Indexed: 09/29/2023]
Abstract
Social media platforms have a wide and influential reach, and as such provide an opportunity to increase vaccine uptake. To date, there is no large-scale, robust evidence on the offline effects of online messaging campaigns. We aimed to test whether pre-tested, persuasive messaging campaigns from UNICEF, disseminated on Facebook, influenced COVID-19 vaccine uptake in Ukraine, India, and Pakistan. In Ukraine, we deployed a stepped-wedge randomized controlled trial (RCT). Half of the 24 oblasts (provinces) received five weeks of the intervention, the other half ten weeks of the intervention. In India, an RCT with an augmented synthetic control was conducted in five states (Bihar, Chhattisgarh, Jharkhand, Madhya Pradesh, Rajasthan), whereby 40 out of 174 districts were randomized to receive six weeks of intervention. In Pakistan we deployed a pre-post design, whereby 25 city districts received six weeks of the intervention. Weekly COVID-19 vaccination data was sourced through government databases. Using Poisson regression models, the association between the intervention and vaccine uptake was estimated. In Ukraine we conducted a survey among Facebook users at three time points during the RCT, to ascertain vaccination intentions and trust in vaccines. The campaigns reached more than 110 million Facebook users and garnered 2.9 million clicks. In Ukraine, we found that the intervention did not affect oblast-level vaccination coverage (Relative Risk (RR): 0.93, 95% Confidence Interval (CI) 0.86-1.01). Similarly, in India and Pakistan we found no effect of our intervention (India: RR 0.85, 95% CI 0.70-1.04; Pakistan: RR 0.64, 95% CI 0.01-29.9). The survey among Facebook users in Ukraine showed that trust in vaccines and information sources was an important predictor of vaccination status and intention to get vaccinated. Our campaigns on Facebook had a wide reach, which did not translate in shifting behaviours. Timing and external events may have limited the effectiveness of our interventions.
Collapse
Affiliation(s)
- Maike Winters
- Yale Institute for Global Health, Yale University, New Haven, Connecticut, United States of America
- Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America
| | - Sarah Christie
- Yale Institute for Global Health, Yale University, New Haven, Connecticut, United States of America
- Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America
| | | | - Amyn A. Malik
- Yale Institute for Global Health, Yale University, New Haven, Connecticut, United States of America
- Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America
| | - Scott Bokemper
- Institution for Social and Policy Studies, Yale University, New Haven, Connecticut, United States of America
- Center for the Study of American Politics, Yale University, New Haven, Connecticut, United States of America
| | | | - Brian Boye
- UNICEF Country Office India, New Delhi, India
| | | | - Zara Jamil
- UNICEF Country Office, Karachi, Pakistan
| | - Taha Tariq
- UNICEF Country Office, Karachi, Pakistan
| | | | | | | | - Elliott Paintsil
- Yale Institute for Global Health, Yale University, New Haven, Connecticut, United States of America
| | - Alexandra Faller
- The Public Good Projects, Alexandria, Virginia, United States of America
| | - Andreea Seusan
- The Public Good Projects, Alexandria, Virginia, United States of America
| | - Erika Bonnevie
- The Public Good Projects, Alexandria, Virginia, United States of America
| | - Joe Smyser
- The Public Good Projects, Alexandria, Virginia, United States of America
| | - Kadeem Khan
- Meta Platforms Inc., Menlo Park, California, United States of America
| | - Mohamed Gulaid
- Meta Platforms Inc., Menlo Park, California, United States of America
| | - Sarah Francis
- Team Upswell, Seattle, Washington, United States of America
| | - Joshua L. Warren
- Peter O’Donnell Jr. School of Public Health, University of Texas Southwestern, Dallas, Texas, United States of America
| | | | - Saad B. Omer
- Yale Institute for Global Health, Yale University, New Haven, Connecticut, United States of America
- Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America
- Peter O’Donnell Jr. School of Public Health, University of Texas Southwestern, Dallas, Texas, United States of America
| |
Collapse
|
50
|
Mondera F, Cammalleri V, Forestiero FM, Turatto F, Direnzo GFM, Napoli A, Pirelli F, Razafimpanana N, Rossi E, Baccolini V, Cinti L, Marzuillo C, Barra M, Antonelli G, Badiani A, Villari P. Adherence to SARS-CoV-2 Vaccination Recommendations among Patients with Substance Use Disorders: A Cross-Sectional Study in Rome, Italy. Vaccines (Basel) 2023; 11:1434. [PMID: 37766111 PMCID: PMC10538200 DOI: 10.3390/vaccines11091434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2023] [Revised: 08/25/2023] [Accepted: 08/29/2023] [Indexed: 09/29/2023] Open
Abstract
Adherence to vaccination recommendations is a challenge for national immunization programs. We quantified adherence to COVID-19 vaccination recommendations in people with substance use disorders (SUDs) attending an outpatient addiction center in Rome, Italy; we investigated the determinants of adherence, and also analyzed patient risk perception and compliance with preventive measures. A multivariable logistic regression model identified predictors of adherence to vaccination recommendations, with statistical validity tested by estimating adjusted odds ratios (aORs) and 95% confidence intervals (CIs). From December 2021 to January 2022, 200 SUD patients completed a questionnaire, 80% of whom reported being vaccinated against SARS-CoV-2 (minimum one dose). Negative predictors of vaccine uptake included being non-Italian (aOR: 0.36, 95% CI: 0.13-0.97), having coexisting comorbidities (aOR: 0.35, 95% CI: 0.13-0.95), and previous use of heroin (aOR: 0.24, 95% CI: 0.08-0.71). No difference was found for cocaine use, demographic characteristics, previous COVID-19 infection, methadone therapy, or compliance with preventive measures. Major reasons for non-adherence to vaccination recommendations were fear of side effects, insufficient recognition of the importance of vaccination, bureaucratic issues, and lack of trust in the authorities. Given their vulnerability, additional efforts are needed to facilitate access to vaccination for people with SUDs, and to limit disinformation around vaccines..
Collapse
Affiliation(s)
- Francesco Mondera
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy; (V.C.); (F.M.F.); (F.T.); (V.B.); (C.M.); (P.V.)
| | - Vincenzo Cammalleri
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy; (V.C.); (F.M.F.); (F.T.); (V.B.); (C.M.); (P.V.)
| | - Francesca Maria Forestiero
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy; (V.C.); (F.M.F.); (F.T.); (V.B.); (C.M.); (P.V.)
| | - Federica Turatto
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy; (V.C.); (F.M.F.); (F.T.); (V.B.); (C.M.); (P.V.)
| | | | - Anna Napoli
- Department of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy; (A.N.); (L.C.); (G.A.)
| | - Francesca Pirelli
- Department of Physiology and Pharmacology, Sapienza University of Rome, 00185 Rome, Italy; (F.P.); (N.R.)
| | - Nirinalisera Razafimpanana
- Department of Physiology and Pharmacology, Sapienza University of Rome, 00185 Rome, Italy; (F.P.); (N.R.)
| | - Ettore Rossi
- Villa Maraini Foundation, 00151 Rome, Italy; (G.F.M.D.); (E.R.); (M.B.); (A.B.)
| | - Valentina Baccolini
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy; (V.C.); (F.M.F.); (F.T.); (V.B.); (C.M.); (P.V.)
| | - Lilia Cinti
- Department of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy; (A.N.); (L.C.); (G.A.)
| | - Carolina Marzuillo
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy; (V.C.); (F.M.F.); (F.T.); (V.B.); (C.M.); (P.V.)
| | - Massimo Barra
- Villa Maraini Foundation, 00151 Rome, Italy; (G.F.M.D.); (E.R.); (M.B.); (A.B.)
| | - Guido Antonelli
- Department of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy; (A.N.); (L.C.); (G.A.)
| | - Aldo Badiani
- Villa Maraini Foundation, 00151 Rome, Italy; (G.F.M.D.); (E.R.); (M.B.); (A.B.)
- Department of Physiology and Pharmacology, Sapienza University of Rome, 00185 Rome, Italy; (F.P.); (N.R.)
| | - Paolo Villari
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy; (V.C.); (F.M.F.); (F.T.); (V.B.); (C.M.); (P.V.)
| |
Collapse
|